MS News & Perspectives: Recent Episodes
MS News Today
Multiple Sclerosis News Today seeks to fill an unmet need in healthcare news journalism by providing patients and their families with a reliable news journal on MS that they can engage with on a daily basis for the latest news and MS resources.
Bruce Bebo is the Executive Vice President of Research at the National MS Society and leads the team that develops and implements the Society's comprehensive research strategy. He has been instrumental in advancing the NMSS Pathways to Cures global research strategy and has served on various international scientific committees.
Tune in as Dr. Bebo discusses the inspiration behind his dedication to MS advocacy and research, his advice for aspiring advocates, and his predictions for the next major advancements to impact the MS community.
LinkedIN: https://www.linkedin.com/in/bruce-bebo-9b0961a/
National MS Society: https://www.nationalmssociety.org/
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram – www.instagram.com/msnewstoday
Facebook – www.facebook.com/msnewstoday/
For more news on Multiple Sclerosis visit: www.instagram.com/msnewstoday/
Jenn sits with Dr. Raj Dasgupta, quadruple board-certified physician and regular medical media consultant by MS News Today
Jeremiah Robison, Founder and CEO of Cionic, is a leader in advancing human mobility. His personal journey, deeply impacted by his daughter's cerebral palsy diagnosis, led him to establish Cionic in 2018. His bold vision for the company is to leverage software, hardware, and machine learning to restore movement throughout the human body, beginning with walking.
Join them as they delve into the Neural Sleeve 2, which has been recognized by Time Magazine as one of the greatest inventions of 2025 for the second time. They will discuss what motivated Cionic to develop the second-generation Neural Sleeve and its significant impact on individuals facing mobility challenges.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram – www.instagram.com/msnewstoday
Facebook – www.facebook.com/msnewstoday/
For more news on Multiple Sclerosis visit: www.instagram.com/msnewstoday/
Katherine Pickett is a Silver Spring, Maryland-based writer and avid cyclist. She completed the Chesapeake Challenge in 2023 and lives with epilepsy, a chronic illness that informs her deep understanding of her character’s journey.
Join them as they discuss Katherine’s book and the main character who lives with MS, what inspired her to create this character, Debra, and what she hopes the takeaway will be for her readers.
LI https://www.linkedin.com/in/popeditingkatherine
IG https://www.instagram.com/kpickett_editor/
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram – www.instagram.com/msnewstoday
Facebook – www.instagram.com/msnewstoday/
Twitter – www.instagram.com/msnewstoday/
For more news on Multiple Sclerosis visit: www.instagram.com/msnewstoday/
Dr. Sharon Stoll is a board-certified neurologist, neuroimmunologist, and assistant professor in the Department of Neurology at Yale School of Medicine. She is also a medical editor, correspondent, and someone who lives with multiple sclerosis herself.
In this episode, Dr. Stoll shares her unique perspective on going from treating MS to living with it, the groundbreaking MS research she’s leading, and how she’s training the next generation of neurologists to better understand and care for people with multiple sclerosis.
Tune in for an inspiring and insightful conversation that blends medical expertise with personal experience—offering valuable takeaways for anyone interested in MS care, research, and advocacy.
IG https://www.instagram.com/drsharonstoll/?hl=en
Linkedin https://www.linkedin.com/in/sharon-s-stoll-a9268078/
X https://www.instagram.com/drsharonstoll/?hl=en
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram – www.instagram.com/msnewstoday
Facebook – www.instagram.com/msnewstoday/
Twitter – www.instagram.com/msnewstoday/
For more news on Multiple Sclerosis visit: https://multiplesclerosisnewstoday.com/
Aaron Boster, MD, is a board-certified neurologist specializing in MS and related central nervous system inflammatory disorders. He decided to become an MS doctor at age 12 as he watched his uncle Mark suffer from the disease in an era before treatment was available.
Join them as they talk about the importance of discussing difficult-to broach topics, the benefits of a comprehensive care team, and what Dr. Boster sees as the next game-changing news for the MS community.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram – www.instagram.com/msnewstoday
Facebook – www.facebook.com/multiplesclerosisnewstoday
X – x.com/MSNewsToday
For more news on MS, visit: www.instagram.com/msnewstoday/
Brandon Beaber, MD, is a neuroimmunologist and MS specialist based at Kaiser Permanente in Los Angeles. He’s amassed more than 36,000 followers on YouTube by using engaging imagery to break down some of the more complicated facets of MS for those living with the condition.
Join them as they discuss the varied nature of MS, aging with the disease, and potential clinical trials for those over 55.
YouTube https://www.youtube.com/c/DrBrandonBeaber
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram – www.instagram.com/msnewstoday
Facebook – www.facebook.com/multiplesclerosisnewstoday
X – x.com/MSNewsToday
For more news on MS, visit: www.instagram.com/msnewstoday/
Ben Hofmeister was diagnosed with primary progressive MS in 2014, ending a 22-year career in the U.S. Army as both a Ranger and Green Beret. After being inspired by the writing of others with MS, he decided to add his own voice to the community.
Listen in as they discuss how to live a fun and fulfilling life with a serious disease, how writing helps Ben with his own MS, and what inspires him to keep giving it his best.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram – www.instagram.com/msnewstoday
Facebook – www.facebook.com/multiplesclerosisnewstoday
X – x.com/MSNewsToday
For more news on MS, visit: www.instagram.com/msnewstoday/
Damian Washington is an actor, comedian, voiceover guru, and MS influencer with more than 5,000 followers on his YouTube channel, NoStressMS. His content creation and comedic take on MS have made him a mainstay in the MS community.
Join the two as they discuss the power of laughter and levity, the capitulation of Damian’s own MS journey, and his passion for helping others navigate their lives with levity and love.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram – www.instagram.com/msnewstoday
Facebook – www.facebook.com/multiplesclerosisnewstoday
X – x.com/MSNewsToday
For more news on MS, visit: www.instagram.com/msnewstoday/
Sam Greenberg is the founder of MS4MS, a nonprofit dedicated to helping those with MS by fundraising and supporting research institutions in search of a cure for the disease.
Join them as they discuss how Sam’s love of sports and passion for helping the MS community merged to create MS4MS. They also talk about how the foundation gives back to both research institutions and the community and how those with MS continue to inspire and shift Sam’s perspective on life.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram – www.instagram.com/msnewstoday
Facebook – www.facebook.com/multiplesclerosisnewstoday
X – x.com/MSNewsToday
For more news on MS, visit: www.instagram.com/msnewstoday/
After 24 years with the National MS Society, most recently as Chief Advocacy, Services and Science Officer, Dr. Tim Coetzee is the new President and CEO of the Society. Serving the Society has been a driving force in his life’s work and he is eager to build on the amazing achievements that have been accomplished with the organization over the years.
Join them as they discuss how this position differs from his last, what new initiatives he hopes to bring to the Society, and what short and long term visions he has for the Society and the MS community.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram – www.instagram.com/msnewstoday
Facebook – www.facebook.com/multiplesclerosisnewstoday
X – x.com/MSNewsToday
For more news on MS, visit: www.instagram.com/msnewstoday/
Nancy Davis is an entrepreneur and philanthropist best known for her signature jewelry line, Peace and Love, and her two foundations, Race to Erase MS and Cure Addiction Now. Having raised over $55 million dollars toward finding a cure for MS, the Center Without Walls (part of Race to Erase MS) offers a collaborative approach to hasten research and discovery among the world’s premier medical, scientific, and research communities.
Join them as they discuss the impact Race to Erase MS has had on the MS landscape, how DMT research and development have accelerated as a result, and how Nancy finds joy amid her own battle with MS.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram – www.instagram.com/msnewstoday
Facebook – www.facebook.com/multiplesclerosisnewstoday
X – x.com/MSNewsToday
For more news on MS, visit: www.instagram.com/msnewstoday/
Amy Behimer is a Doctor of Pharmacy and National Board Certified Health and Wellness Coach who helps people feel healthy amid autoimmune diagnoses. Living with MS, Amy has a unique understanding of the challenges such patients face, and her coaching emphasizes physical, mental, and emotional wellness.
Join them as they discuss Amy’s own diagnosis and her decision to become a life coach. She also touches on what inspired her to help the autoimmune disease community and how others can start to make the shift from simply managing their autoimmune disease to creating autoimmune health.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram – www.instagram.com/msnewstoday
Facebook – www.facebook.com/multiplesclerosisnewstoday
X – x.com/MSNewsToday
For more news on MS, visit: www.instagram.com/msnewstoday/
Lindsay Kelly is a certified life coach and helps people navigate unexpected life transitions. She is also a social media influencer and caregiver for her husband, Rhead, who, because of the severity of his MS, resides in assisted living.
Join them as they discuss the difficult decision to choose assisted living for Rhead, why she uses social media to elevate understanding of MS, and how her family stays close despite their unique situation.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram – www.instagram.com/msnewstoday
Facebook – www.facebook.com/multiplesclerosisnewstoday
X – x.com/MSNewsToday
Charisse Litchman, MD, is co-founder and chief medical officer of BeCare Link, an AI-driven platform that helps patients take charge of their neurological health. A practicing neurologist and a former faculty member at Yale School of Medicine, Dr. Litchman leverages her expertise in medicine and advances in technology to empower patients and improve outcomes.
Listen in as they discuss what inspired Dr. Litchman to become a neurologist, her motivation behind the creation of BeCare Link, and what future developments lie ahead.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram – www.instagram.com/msnewstoday
Facebook – www.facebook.com/multiplesclerosisnewstoday
X – x.com/MSNewsToday
Since his own diagnosis in 2004, Michael Weiss has dedicated himself to advocating and fundraising on behalf of MS organizations and patients. His innumerable achievements and fundraising efforts have led him to his current position as a patient ambassador and advisory board member with the non-profit organization MS4MS.
Join them as they discuss the mental and physical challenges that can accompany MS, why it’s important to be comfortable with being “not OK,” and wisdom for newly diagnosed patients.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram – www.instagram.com/msnewstoday
Facebook – www.facebook.com/multiplesclerosisnewstoday
X – x.com/MSNewsToday
On the latest episode, Jenn talks with Jeremiah Robison, founder of CIONIC and its FDA-cleared Neural Sleeve — the first product to combine sensing, analysis, and augmentation into a wearable garment for mobility.
Join them as they discuss the importance of practical application when it comes to mobility devices, what differentiates the CIONIC Neural Sleeve from other functional electrical stimulation devices, and why Jeremiah is just getting started on his mission to change the landscape of wearable technology.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
UCLA basketball player Blake Arnet lost his mom, Brigitte, to MS the summer before his junior year. This tragedy left Blake and his family inspired to help fight this disease in Brigitte’s honor. His background in basketball, sports coaching, and entrepreneurial talent helped him establish Dunk MS.
Join Jenn and Blake as they discuss the profound impact of losing a parent to MS at such a young age, how grief turned to inspiration, and what exciting things everyone can expect at Dunk MS 2024 on Saturday, May 18.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Tim Coetzee, PhD, serves as the National MS Society’s Chief Advocacy, Services, and Science Officer. In this role, he leads the organization’s state and federal advocacy, educational, and support programs for people with MS and spearheads healthcare professional engagement and training and global research programs.
Join them as they discuss the society’s many services and programs, its search for new innovators to aid in groundbreaking research, and Tim’s own commitment to finding a cure for MS.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Daniel Ontaneda, MD, PhD, FAAN, is a staff neurologist and Director of Research for the Mellen Center for Multiple Sclerosis, part of the Neurological Institute at Cleveland Clinic.
Join them as they discuss the misdiagnosis of MS, gaps in current diagnostic criteria, and how artificial intelligence could be used to aid diagnostic accuracy.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
In June 2018, Todd went from building start-ups in Silicon Valley to becoming the primary caregiver of and patient advocate for his mom and subsequently his dad. In looking for support and resources, Todd saw a significant unmet need.
Join Jenn and Todd as they discuss the importance of creating resources solely for caregivers. They touch on what caregivers need, how they can get those needs met, and what inspired Todd to create My Care Friends — a free, comprehensive, and growing resource for caregivers, advocates, and family members.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Award-winning actress Jamie-Lynn Sigler talks openly about living with multiple sclerosis, including her diagnosis at age 20 and her decision to keep it a secret for 16 years. She also shares what surprised her most once her diagnosis became public.
Neuroimmunologist, Dr. Sharon Stoll is both a practicing neurologist and scientist, creating the first intrathecal baclofen pump for severe MS-related spasticity. Dr. Stoll discusses symptom management and healthy living with MS and reveals something of her own strategies for the first time.
Join them for a candid discussion about overcoming everyday challenges and celebrating oneself in the midst of living with a chronic illness.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
After her MS diagnosis, Julie Stamm made it her mission to educate, support, and advocate for others battling chronic illnesses. After the birth of her son in 2016, Julie shifted her focus to supporting the children of parents with a chronic illness. Her children’s book entitled “Some Days: A Tale of Love, Ice Cream, and My Mom’s Chronic Illness” was created to normalize differing abilities and amplify how each of us can thrive in spite of our challenges.
Join them as they discuss Julie’s inspiration to normalize disability for children, her follow-up to her children’s book, and how she lives well with MS.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Dr. Boster is a board-certified neurologist specializing in MS at the Boster Center for MS in Columbus, Ohio. Dr. Boster made the decision to become an MS doctor at the age of 12, as he watched his uncle Mark suffer from the disease in an era before MS treatment was available.
Join Jenn and Dr. Boster as they discuss the passion behind his practice, how he translates MS care through his YouTube and social media channels, and takeaways for living your best life with MS.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Michael Weiss’s 2004 diagnosis of MS propelled him to become an active advocate in the MS community. From leadership roles and speaking engagements to fundraising and his current role as a member of the NARCRMS Patient Advisory Board; Michael is a powerful advocate for all with MS.
Join them as they discuss his journey from diagnosis to advocate, how others can get involved in their communities, and the importance of advocating for one’s care.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Kathy Chester is the host of the Move It or Lose It podcast and leads Women Who Disrupt MS, a support group facilitated through the Multiple Sclerosis Foundation. Diagnosed with MS more than 20 years ago, Kathy also established the Disrupt Fitness gym: a program combining circuit and interval training to create the most efficient workout
Join them as they discuss what inspired Kathy to create Disrupt Fitness, what differentiates her program from conventional workouts, and what the overarching benefits are of staying active with MS.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Elizabeth Yarnell is a traditional naturopath focused on how chronic inflammation influences health. Her 1999 MS diagnosis inspired her to eat healthier and eventually patent Glorious One-Pot Meals, a cooking method to meet her need for healthy, quick, and easy dinners.
Join them as they discuss the connection between inflammation and diet and how Yarnell’s MS responded to healthy eating. She also shares the catalyst that led her to pursue a career as a traditional naturopath and bestselling author.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday/
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Megan Evans used her background in dance and theater to create the MS Stage, a program that has helped cope with the challenges of living with MS. Megan uses movement, meditation, and mindfulness practices to help others move themselves onto a healing path.
Join Jenn and Megan them as they discuss her journey with the disease, what inspired her to start the MS Stage, and how believing in and loving her MS has helped her lead others to do the same.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday/
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Diagnosed in 1994, Dominic went from patient to advocate, founding TheMSguide in 2021. He now hosts inspirational patient leaders and experts in the field of MS Neurology, making TheMSGuide a successful patient-to-patient YouTube channel where people across the world can share their experiences of MS.
Join Jeann and Dominic as they discuss what inspires him to educate and advocate for the MS community, the positive changes he has made for disabled Eurail passengers, and how his mindset helps him navigate life with a progressive disease.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday/
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Jenn speaks with Vice President of Programs for CanDo MS, Kathy Costello. Can Do MS is a nonprofit organization that delivers health and wellness education programs on exercise, nutrition, symptom management, and motivation to support families living with MS.
Join them as they discuss Kathy’s role at Can Do MS, and the programs, webinars and community-based activities Can Do MS offers.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday/
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Imagine living with MS with no nearby services and the closest medical care a 3-hour flight away. Melissa Cook spent 20 years managing her disease remotely and chronicling her daily experiences in her blog, MSSymptoms.me. After she could no longer teach, she went on medical disability.
Join Jenn and Melissa as they discuss how Melissa managed her MS and what inspired her to write “The Call of the Last Frontier: The True Story of a Woman’s Twenty-Year Alaska Adventure.”
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday/
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads about a U.K. study reporting that the risk of developing multiple sclerosis was not influenced by the consumption of alcohol.
He also reads the column “I’m Giving Myself the Gift of Grace This Christmas” by Jennifer Powell, from her column “Silver Linings.”
We will be pausing our Audio News episodes indefinitely. You can still access our news via our website at www.multiplesclerosisnewstoday.com. You can also find us on social media or join our forums. Thank you.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about the B-cell depleting therapy Briumvi (ublituximab) being approved in the U.S. for adults with relapsing forms of MS.
He also reads “‘Twas the Night Before Christmas’: A Multiple Sclerosis Parody” by Jamie Hughes, from her column “A Life In Letters.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about new clinical trial in Iran testing the effects of ginger supplements in patients with RRMS.
He also reads “I Am What I Am: Embracing the Highs and Lows of MS” by
Jamie Hughes, from her column “A Life In Letters.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about a masitinib trial that is expected to include up to 800 participants at about 75 sites in Europe, North America, Israel, and Africa.
He also reads “This New Year, I Resolve to Let Myself Hope” by Benjamin Hofmeister, from his column “Chairborne.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how severing the lower part of the vagus nerve that connects the brain and gut led to less myelin loss in an MS mouse model.
He also reads “Could Your Hip Pain Be Related to Your MS Steroid Treatments?” by Ed Tobias, from his column “The MS Wire.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the news about a natural supplement from Persian medicine that led to improvements in physical activity for MS patients with mobility issues.
He also reads “MS News Notes: Brain Stimulation, Bright Light, ABA-101, Foralumab” by Ed Tobias, from his column “The MS Wire.” ===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article reporting on how symptoms that are evident before MS begins could help predict disease type and likely course.
He also reads “MS News Notes: DMT Costs, Copaxone, EBV, Rituximab” by Ed Tobias, from his column “The MS Wire.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads about a study that shows how intermittent fasting diet plan can lead to immune cell and metabolic changes in MS patients.
He also reads “‘Stress and MS Are Bad Companions, So Take It Easy This Holiday Season” by Ed Tobias, from his column “The MS Wire.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article reporting that Canadians with MS said cannabis was highly effective in treating pain, stress, fatigue, and muscle spasms.
He also reads “How I Plan to Have a Cracking Christmas With MS” by Beth Ullah, from her column “Through the Looking Glass.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about a machine learning algorithm that uses genetic, clinical, and demographic information to more accurately predict disease severity.
He also reads “MS News Notes: DMT Costs, Copaxone, EBV, Rituximab” by Ed Tobias, from his column “The MS Wire.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads about a study on subjective cognitive impairment, or self-reported problems, that predicted worse employment status after two years for MS patients.
He also reads “Being Able to Laugh at Yourself Is Vital When Living With MS” by Benjamin Hofmeister, from his column “Chairborne.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Dr. Terry Wahls is a clinical professor of medicine at the University of Iowa where she teaches internal medicine residents, sees patients in a traumatic brain injury clinic, and conducts clinical trials. She also has SPMS.
Join Jen and Dr. Wahls as they discuss her diagnosis and how she reclaimed her health through her own ‘Wahls’ Protocol; a combination of functional medicine, supplements and intensive nutrition.
Find out about recruitment for her study, Efficacy of Diet on Quality of Life in Multiple Sclerosis (EDQ-MS),
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday/
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads about a study on noninvasive brain stimulation that was able to improve fatigue, spasticity, pain, and quality of life in patients with MS.
He also reads “‘Time Is Brain’: Managing Brain Atrophy With MS” by Ed Tobias, from his column “The MS Wire.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads
a news article on how differences in the gut microbiome have been linked to an altered risk of developing low immune cell counts following treatment with Tecfidera.
He also reads a second article reporting that Tevogen Bio has announced plans to develop T-cell therapies that target the Epstein-Barr virus.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the news article about a patent that has been filed in Australia for EmtinB in combination with Copaxone as a potential MS treatment.
He also reads about a new CAR T-cell therapy that eliminates the self-reactive immune cells that drive MS without destroying healthy immune cells.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news piece on how fewer than 1 in 5 people with MS or other neurologic conditions in the U.S. are on new-to-market medications.
He also reads “How I Plan to Have a Cracking Christmas With MS” by Beth Ullah, from her column “Through the Looking Glass.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article on how climate change can worsen symptoms and risk relapses in people with MS.
He also reads “Sweeter Than Honey: Finding the Balance That Works for You” by Jamie Hughes, from his column “A Life in Letters.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reports on how individuals with PPMS have significantly higher concentrations of specific inflammation biomarkers in their spinal fluid than healthy people. He also reads MS News Notes: Climate Change, MS Progression, Brain Shrinkage” by Ed Tobias, from his column “The MS Wire.”
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on a dietary supplement called Neuroaspis plp10 that significantly lowered relapse rates and slowed disability progression among people with RRMS.
He also reads “Dr. Amazon Takes a Third Jab at Medical Care” by Ed Tobias, from his column “The MS Wire."
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how a trial testing NVG-291 has completed dosing in a final group of healthy postmenopausal women.
He also reads “Striking a Balance Between Self-pity and Giving Yourself Grace” by Benjamin Hofmeister, from his column “Chairborne.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads about the calls for new methods to classify MS that reflect the disease's underlying biology.
He also reads “MS News Notes: Stem Cell Therapy, EBV Vaccine, Diabetes, Diets” by Ed Tobias, from his column “The MS Wire.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how relapsing-remitting MS patients have not had a confirmed disability progression following two years of treatment with vidofludimus calcium.
He also reads “The MS Hug: A Frightening Embrace You’d Rather Not Have” by Ed Tobias, from his column “The MS Wire.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how MS patients without substantial disability live about 30 years past their diagnosis, while survival decreases as disability progresses.
He also reads “How I Survived My Odyssey With a Urinary Tract Infection” by Stephen De Marzo, from his column “Goldilochs.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how researchers sought to understand what happens to the immune system after stem cell transplants in people with MS.
He also reads “MS News Notes: Foralumab, ATA188, Precision Care, PoNS Trial” by Ed Tobias, from his column “The MS Wire.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Dr. Payrovi is the founder of TRUE Medicine, an online wellness program for multiple sclerosis. She practices integrative and functional medicine at Stanford’s Center for Integrative Medicine.
She also has multiple sclerosis.
Join Jenn and Dr.Payrovi as they discuss the benefits of functional and integrative medicine, grieving the loss of a career in anesthesiology, the beauty of reinventing oneself, and the healing power of community.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday/
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads about dietary interventions that may help ease fatigue and improve quality of life in people with multiple sclerosis.
He also reads “These Home Accommodations Can Make Living With MS Easier” by Ed Tobias, from his column “The MS Wire”.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about a grant supporting an Australian-led research team aiming to better understand how EBV may be acting as a trigger for MS.
He also reads “MS News Notes: Stem Cell Transplant Versus DMTs, Treatment Efficacy, Cancer Risk, Employment” by Ed Tobias, from his column “The MS Wire.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how stem cell transplant is superior to Gilenya and Tysabri at preventing relapses and easing disability in RRMS patients.
He also reads another report on how early use of DMTs may lead to lower levels of disability but does not appear to slow disability progression over time.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news report on ATA188, a treatment targeting the Epstein-Barr virus which could be integral in treating progressive MS.
He also reads a news article reporting on how ublituximab works better than Aubagio at easing disability in patients with relapsing MS.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article reporting on how exposure to high-efficacy DMTs is linked to an increased risk of cervical abnormalities in women with MS.
He also reads another news article on Tecfidera reducing the risk of experiencing the first MS symptoms in adults with radiologically isolated syndrome.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how genetic variants in genes mostly active in the central nervous system are linked to MS severity.
He also reads a report on how the investigational immunotherapy ATA188 continues to ease disability and prevent brain tissue shrinkage in people with progressive forms of multiple sclerosis.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads about a study that shows how new myelin production may be less efficient in late-onset multiple sclerosis patients, which could underlie more severe disease progression.
He also reads “MS News That Caught My Eye Last Week: ECTRIMS, Ocrevus, Kesimpta, Epstein-Barr, DMTs” by Ed Tobias, from his column “The MS Wire”.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how a prior Epstein-Barr virus infection may precede the emergence of a biomarker of nerve damage in presymptomatic MS patients.
He also reads a second article about a study focusing on tap speed on a smartphone keyboard and how it is linked to greater disability and worse function in people with MS. ===================================
Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit: https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how fertility treatments do not appear to significantly increase the risk of relapse in women with multiple sclerosis.
He also reads a news article on how treatment with Ocrevus before or during pregnancy does not seem to increase the risk of major pregnancy or infant complications.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about a study showing that when MS patients stop their disease-modifying treatment, the risk of relapses and disease activity on MRI scans is higher among patients who have RRMS.
He also reads an article on how Ocrevus safely and effectively reduced disease activity in people with early-stage relapsing-remitting multiple sclerosis.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article reporting that the levels of two biomarkers were higher in people with relapsing and progressive MS and most likely to predict how relapsing MS will progress.
He also reads “As Ever, I Prevaricate Before Taking On My Focus: Long COVID-19” by John Connor, from his column “Fall Down Get Up Again”.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how the Mediterranean diet is linked to a lower risk of disability outcomes and symptoms in people with MS.
He also reads “New Gadolinium-based Contrast Agent Elucirem Will Soon Be Available for MRIs” by Ed Tobias, from his column “The MS Wire”.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Jenn talks with Jeremiah Robison, founder of Cionic and their FDA-cleared Neural Sleeve, the first product to combine sensing, analysis and augmentation into a wearable garment for mobility.
Join them as they discuss Jeremiah's primary reason in founding Cionic, his passion for seeing others succeed, and his future plans to support those with mobility issues due to a neurological disease.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday/
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article reporting that lower cholesterol levels in blood and cerebrospinal fluid might correlate with a more severe disease course in multiple sclerosis patients.
He also reads “MS News Notes: Cholesterol and MS Progression, Fatigue, Epstein-Barr” by Ed Tobias, from his column “The MS Wire”.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about a clinical trial where electrical stimulation of the brain eased some measures of spasticity for people with relapsing-remitting MS.
He also reads “MS News Notes: aHSCT, Iron Rim Lesions, Smell Test, Electrical Brain Stimulation” by Ed Tobias, from his column “The MS Wire”.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how neurologists in Colombia agree that sexual dysfunction affects quality of life in major ways for people with multiple sclerosis, but some still don’t ask their patients about it.
He also reads “Is Your Disability Ready for an Emergency Like Hurricane Ian?” by Ed Tobias, from his column “The MS Wire”.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit: https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how evaluating a person’s sense of smell may help monitor disease progression in people with multiple sclerosis. He also reads “Don’t Let the Past and Future Be Obstacles While Living With MS” by Benjamin Hofmeister, from his column “Chairborne”.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how stem cell transplant reduced markers of nerve fiber and myelin damage in people with RRMS.
He also reads “My Wife and I Hit Some Bumps on Elton John’s Yellow Brick Road” by Ed Tobias, from his column “The MS Wire.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article on how the presence of iron rim lesions, which are regions of chronic inflammation seen on MRI scans, may be linked to a more severe disease course in people with multiple sclerosis.
He also reads “MS News That Caught My Eye Last Week: ODRS Test, Kesimpta, Coping Strategies, Dual Tasking” by Ed Tobias, from his column “The MS Wire”.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how six months of treatment with foralumab nasal spray led to significant functional improvements in the second patient with non-active SPMS.
He also reads the latest installment of our “Expert Voices” series, where Dr. Susan Payrovi, MD, answers questions about functional medicine care with MS.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit: multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit: multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how the likelihood of survival is about 7.5 times higher for people with multiple sclerosis who take their disease-modifying treatments as directed.
He also reads “The Smog of Tax Returns: An MS Fairy Tale” by John Connor, from his column “Fall Down, Get Up Again”.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about a study with people with mild and moderate multiple sclerosis that performed worse than healthy people during dual walking or standing and reasoning tasks.
He also reads the column “MS News That Caught My Eye Last Week: Gut Bacteria, Strength Training, Robots, Gilenya Patent” by Ed Tobias, from his column “The MS Wire”.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a new analysis regarding the fact that in Canada, Kesimpta is more cost-effective than other DMTs for treating relapsing-remitting MS.
He also reads “My Wife Says I Should Follow My Own (MS) Advice” by Ed Tobias, from his column “The MS Wire”.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about a study that uncovered how people with SPMS have more microscopic damage in normal-appearing brain tissue than do patients with RRMS.
He also reads the column “All Quiet on the MS Front - Well, Nearly” by John Connor, from his column “Fall Down, Get Up Again”.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how ten weeks of lower limb fast-velocity concentric resistance training led to muscle strength gains in both the upper and lower limbs in people with MS.
He also reads “An Interpretation of My MS Dreams: What Freud Might Say” by Ed Tobias, from his column “The MS Wire”.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit: https://multiplesclerosisnewstoday.com/forums/
Michigan couple Dan and Jennifer Digmann both have MS. Life with Dan’s RRMS and Jen’s SPMS can be tough, but so are the Digmanns. Listen in as they speak candidly with Jenn about marriage, navigating and overcoming obstacles, and how advocating for award-winning legislative change fueled a desire to help others do the same.
Check out their blog and podcast, ACoupleTakesOnMS.com.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday/
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how six months of treatment with foralumab nasal spray led to significant functional improvements in the second patient with non-active SPMS.
He also reads “MS News That Caught My Eye Last Week: EBV, Stem Cell Transplant, NurOwn, Progression Without Relapse” by Ed Tobias, from his column “The MS Wire”.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit: https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how off-label high-efficacy DMTs for people with progressive forms of MS appear to be as effective as on-label, or approved, DMTs.
He also reads the latest installment of our “Expert Voices” series, where Dr. Susan Payrovi, MD, answers questions about functional medicine care with MS.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the news article covering a study about the protective soft membranes covering the brain and spinal cord that could be a target for disease-causing T-cells in MS.
He also reads “My Stubbornness Has Helped and Hindered Me in Life With MS” by Benjamin Hofmeister, from his column “Chairborne”.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article regarding a study that finds that T-cells equipped with receptors primed to recognize the Epstein–Barr virus, leading to attacks, are excessive in people with MS.
He also reads a column by Ed Tobias entitled “Need Help Choosing the Right Medication to Treat Your MS?”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how treatment with medrysone improved repair of myelin in a preclinical study.
He also reads a report by Hawken Miller, “First Descents Prescribes Good Medicine From the Great Outdoors”.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article reporting that an interval dosing of Ocrevus of one month or longer was linked to a fivefold higher risk of MRI-based disease activity.
He also reads “Researchers Hit a Bump on the BTK Inhibitor Road” by Ed Tobias, from his column "The MS Wire".
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article regarding MS patients who had a blood stem cell transplant support.
He also reads the column by John Connor, Fall Down, Get Up again, “Thanks to MS Progression, My Weight Became a Problem”.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about a data-driven algorithm that may help predict when patients convert to secondary progressive multiple sclerosis from a relapsing form of the disease.
He also reads “Do You Cry and Don’t Know Why? It Might Be PBA” by Ed Tobias, from his column “The MS Wire.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how MS incidence was higher among patients with a prior mono diagnosis, usually caused by the Epstein-Barr virus.
He also reads “The Difference Between Living and Existing After My PPMS Diagnosis” by Stephen De Marzo.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads about a study that shows how aquatic exercise can help ease fatigue and improve balance in MS patients.
He also reads “MS News That Caught My Eye Last Week: Epstein-Barr, Aqua Exercise, Diagnosing SPMS, Myelin Repair” by Ed Tobias, from his column “The MS Wire.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how researchers have identified early factors that may affect the trajectory of an MS patient’s long-term quality of life following diagnosis.
He also reads “My MS Makes Getting Sick With a Viral Infection 10 Times Worse”, a column by Benjamin Hofmeister.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how Baclofen, an approved therapy for spasticity in multiple sclerosis patients, promoted myelin repair in preclinical models of the disease.
He also reads “MS and Sex: Everything You Wanted to Know but Were Never Told to Ask”, a column by John Connor.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article on how Clene Nanomedicine’s oral therapy CNM-Au8 eased vision problems and improved neurological function in adults with relapsing-remitting MS.
He also reads “Overcoming MS Setbacks to Find Abundant Love on a Special Day”, a column by Beth Ullah.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how an experimental multiple sclerosis vaccine, PAS002 by Pasithea Therapeutics, is designed to prevent autoimmune attacks against myelin.
He also reads “Seeing Double, and I’m Not Even Drunk”, a column by John Connor.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a newsletter’s first issue is providing information on ways to manage pseudobulbar affect, one of the most underrecognized MS symptoms.
He also reads “MS News That Caught My Eye Last Week: COVID-19 Vaccines, Robot Training, Bladder Treatment, Tysabri”, a column by Ed Tobias.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Amy Sullivan works at the Cleveland Clinic’s Mellen Center for MS, where her research is focused on multiple sclerosis, depression, mood disorders, and psychotherapy. She is passionate about identifying the prevalence of mood disorders in people with MS and finding ways to improve their quality of life.
Listen in as they discuss the prevalence of depression and anxiety in those with MS, how to eradicate the stigma around mental health, and the methodology behind the Cleveland Clinic’s multiple sclerosis mental health program.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday/
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how men with MS show differences in health-related behaviors based on how much they value certain masculine ideals.
He also reads “High Temperatures Make My Brain Become Strangled in Static”, a column by Stephen De Marzo.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how Tysabri outperformed other MS treatments at lessening symptoms and improving work productivity.
He also reads “Sometimes Pushing Boundaries With My MS Management Pays Off” by Beth Ullah, from her column “Through the Looking Glass.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, explains how adding specialized nursing care to community neurology practices for MS patients helped ease their depression and anxiety.
He also reads “New Service Takes a Shark-size Bite out of Medication Costs” by Ed Tobias, from his column “The MS Wire.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about aHSCT, a procedure aimed at “resetting” the immune system, that appears to reduce disability and relapse rates in people with MS.
He also reads “How My MS Diagnosis Journey Became My Origin Story” by Benjamin Hofmeister, from his column “Chairborne”.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how two years of Ocrevus treatment outperformed Rebif at preventing myelin loss in people with relapsing forms of multiple sclerosis.
He also reads “Dreams, Diagnoses, and Disclosures: When to Tell Others About MS” by Ed Tobias, from his column “The MS Wire”.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how people with MS have significantly higher and potentially damaging blood levels of zinc.
He also reads “MS News That Caught My Eye Last Week: Vitamin D, Brain Health, Digoxin, Natalizumab” by Ed Tobias, from his column “The MS Wire”.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, explains how an international team of scientists is calling for more rigorous studies to test whether exercise can help protect the nervous system from damage in people with MS.
He also reads “The Heat Is On: Coping With PPMS and High Temperatures”, a column by Stephen De Marzo.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads about review paper highlighting how while available studies suggest a connection between childhood trauma and MS, more research is needed to understand this link.
He also reads “Can MS, Medical Marijuana, and Guns Safely Coexist?” by Ed Tobias, from his column "The MS Wire”.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the news article about an approved heart med that could promote myelin repair in MS.
He also reads “MS News That Caught My Eye Last Week: Intermittent Fasting, Roe v. Wade, IRLs” by Ed Tobias, from his column "The MS Wire".
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the news article on how a man-made molecule was able to promote myelin repair in a mouse model of MS.
He also reads “A Friend Under the Skin: My Intrathecal Baclofen Pump” by Benjamin Hofmeister, from his column "Chairborne".
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, explains how Labcorp has launched a widely accessible test that measures the levels of NfL, a biomarker of nerve damage, to screen for signs of neurodegenerative diseases such as MS.
He also reads “How to Avoid Trouble While Traveling Internationally With MS Medications”, a column by Ed Tobias.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on a study aimed at developing precise markers of myelination in people with MS.
He also reads “To Everything There Is a Season’: Coping With Grief, Loss, and MS”, a column by Teresa Wright-Johnson.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Kathy Reagan Young is the founder of website and podcast FUMS. She is also the founder of Patients Getting Paid, a membership community that helps people with chronic illnesses find employment that accommodates their health. Join them as they discuss finding purpose outside of MS, the importance of helping others, and how one patient’s voice started a movement. Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday/
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the news article on how data from a small clinical trial showed how an intermittent fasting diet plan led to immune cell and metabolic changes in MS patients. He also reads “I Had to Make Difficult Business Decisions After My PPMS Diagnosis”, a column by Stephen De Marzo. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
In this audio news episode, Price Wooldridge reads an article on how long-term treatment with Zeposia seems to stabilize or improve cognitive function in most adults with relapsing forms of MS.
He also reads “Just Because We Aren’t Relapsing Doesn’t Mean We Are Symptom-free”, a column by Beth Ullah.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how new U.S. enrollments in Phase 3 trials of tolebrutinib for MS have been paused due to some reports of liver injury. He also reads “Trial Results a Setback for US Approval of Nabiximols for MS Spasticity” from Ed Tobias’ column “The MS Wire.” =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge reads an article about how fully vaccinated MS patients who are taking Ocrevus or Gilenya have a higher risk of COVID-19 infection than those on other therapies. He also reads “While Living With MS, Good Planning Is Key to Avoiding Chaos”, a column from Beth Ullah’s “ Through the Looking Glass.” ===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge explains how the safety and efficacy of Mavenclad in a real-world group of RRMS patients, were similar to what was observed in its clinical trials. He also reads “A New Gift Helps Me Stay Cool in the Summer Heat”, by Ed Tobias from his column “The MS Wire.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how researchers found that an MRI technique can be used to accurately identify remyelinated brain lesions in people with multiple sclerosis.
He also reads “The MS Paradox Results in Many Conflicting Feelings”, by Benjamin Hofmeister, from his column “Chairborne.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how the use of pregnancy hormone estriol with Copaxone significantly reduced levels of neurofilament light chain, a marker of nerve damage. He also reads “Fatigue Was One of the First ‘Tells’ of My Primary Progressive MS”, from Stephen De Marco’s column “Goldilochs.” =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge discusses how researchers found tenascins block myelin repair, which could lead to a possible treatment avenue. He also reads “Managing Fatigue and Other Vacation Tips for People With MS”, from Beth Ullah's column, "Through the Looking Glass." =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how ALITHIOS trial participants who started on Kesimpta were about four times more likely to have no MS symptoms than those starting on Aubagio. He also reads “Comparing Cases of Multiple Sclerosis Leads to a Logical Fallacy” by Benjamin Hofmeister, from his column “Chairborne.” =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how TG Therapeutics presented additional Phase 3 trial data indicating that ublituximab improves disability and quality of life in people with MS. He also reads “Why I’m Giving 3 MS Medications Another Try” from Ed Tobias’ column, “The MS Wire.” =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads about a second person with SPMS who showed improvements in walking and reduced inflammation, following three months of treatment with foralumab nasal spray.
He also reads “She Disclosed Her Illness and Got the Job” by Ed Tobias, from his column “The MS Wire.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about Cionic’s Neural Sleeve and how it reduced foot drop and eased other symptoms in a small clinical trial. He also reads “Grappling With the Sensory Overload That Can Come With MS” from Beth Ullah’s column “Through the Looking Glass.” =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a study found that alcohol intake was not associated with the risk of multiple sclerosis, whereas beer intake was linked to an increased risk. He also reads “The Journey Toward My Primary Progressive MS Diagnosis”, from Stephen De Marzo’s column, “Goldilochs.” =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge reads a news article about how Dysport won a positive opinion in Europe for managing urinary incontinence in adults with multiple sclerosis. He also reads “Does Medical Marijuana Help the Pain That Comes With MS”, a column from Ed Tobias’ “The MS Wire.” =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how MS can increase the risk of potentially life-limiting problems like pneumonia, as a team of scientists in the U.S. and China conducted an study to identify the link between MS and mortality risk.
He also reads “MS News That Caught My Eye Last Week: Evusheld, Immunotherapy, Blood Test, Aubagio”, from Ed Tobias’ column “The MS Wire.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Annie Brewster is an assistant professor of medicine at Harvard Medical School, a practicing physician at Massachusetts General Hospital in Boston, and the founder and executive director of Health Story Collaborative. She is also a person with multiple sclerosis. Listen as they discuss how being a patient shifted Dr. Brewster’s perception of medical care, and what inspired her to share her own personal story in her book, "The Healing Power of Storytelling: Using Personal Narrative to Navigate Illness, Trauma and Loss.” Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday/
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discuses how Evusheld was found to boost immune responses against COVID-19 among vaccinated multiple sclerosis patients. He also reads the new Expert Voices installment, in which Dawn Ehde, PhD, answers questions about pain management for people with multiple sclerosis. ===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a phase 1/2 clinical trial is evaluating the safety and effectiveness of a cutting-edge immunotherapy called extracorporeal photopheresis in people with MS.
He also reads “How I’m Making the Most of My Limited Energy as Someone With MS”, from Jamie Hughes’ column, “A Life in Letters.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how the pandemic’s negative aspects were associated with worse MS disability in patients living in Italy and in the U.S. He also reads “Romance Means We Took the Weekend Off MS, Nearly”, from John Connor’s column “Fall Down, Get Up Again.” =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Follow us on social media!
Instagram - https://www.instagram.com/msnewstoday/
Twitter - https://twitter.com/MSNewsToday
Facebook - https://www.facebook.com/multiplesclerosisnewstoday/
Our #31DaysOfMS campaign is highlighting the different ways to do life with MS. Melody Sapien and Rennie Rankin, two of the campaign’s contributors, chatted with us live about their experience. Listen to this conversation with Melody and Rennie here and be sure to read their stories on our MS News Today website. Rennie's story: https://bit.ly/38bmOdc
Melody's story: https://bit.ly/3wNADab
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, explains how more than half of multiple sclerosis patients on Aubagio showed no evidence of disease activity after two years, according to a study. He also reads”A Road Trip From Florida Maryland With No Bladder Incontinence”, by Ed Tobias, from his column “The MS Wire.” =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on the effectiveness of Ponvory that has emerged from analyzing a database of multiple sclerosis clinical trials compiled by Certara. He also reads “Tipping the Scale: When Today’s Choices Become Tomorrow’s Consequences”, from Beth Ullah’s column “Through the Looking Glass.” =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how the U.S. Department of Defense awarded $3.9 million to study the mental and physical health of multiple sclerosis patients following a low-glycemic diet.
He also reads “How I Get Through My Days - More Importantly, Please Tell Me How You Get Through Yours”, from John Connor’s column, “Fall Down, Get Up Again’.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how lesions in three specific brain regions may help distinguish people with MS from those with other inflammatory brain diseases He also reads “Another Busted Cane Leads to a Search for Something Better” from Ed Tobias' column "The MS Wire." =================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how people with progressive forms of multiple sclerosis, and those with greater MS-related disability, have a much higher risk of serious infections. He also reads “Hoping for Medical Debt Relief? This Nonprofit Just Might Help”, by Ed Tobias, from his column "The MS Wire.” =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how high free vitamin D levels in circulation before the age of 20 are linked with a lower risk of developing multiple sclerosis later in life. He also reads “MS News That Caught My Eye Last Week: DMTs and Symptoms, Aquatic Exercise, Infections”. by Ed Tobias, from his column "The MS Wire." =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge discusses how ABX-002, Autobahn Therapeutics' experimental treatment for multiple sclerosis, promoted restoration of the myelin sheath.
He also reads “It’s Time to Start Thinking About Seasonal Adjustments and MS" by Beth Ullah, from her column "Through the Looking Glass."
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how among MS patients on rituximab, higher immune B-cell counts are predictive of a better antibody-based response to a COVID-19 vaccine. He also reads “No Crisis, No Column? OK, Fine: Everything Takes So Long With MS” from John Connor's column, "Fall Down, Get Up Again."
=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how a registry data study found about half of newly diagnosed RRMS patients burdened by 'hidden' disabilities including fatigue and depression. He also reads “After Standing Still, Finding My Next Step”, from Beth Ullah's column, "Through the Looking Glass." =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
As a Physical Therapist & Multiple Sclerosis Specialist, Dr.Gretchen Hawley FT, DFT, MSCS is passionate about helping people with multiple sclerosis gain strength, mobility, and independence. Listen in as Jenn and Dr. Hawley discuss the online MS wellness program, The MSing Link, what inspired Dr. Hawley to specialize in MS, and the creative ways you can seek wellness. Join the conversation on our MS forums: http://www.multiplesclerosisnewstoday.com/forums/ Follow us on social media:
Instagram - http://www.instagram.com/msnewstoday/
Facebook - http://www.facebook.com/multiplesclerosisnewstoday/
Twitter - http://www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
http://www.multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how findings suggest that disease severity, brain volume loss, and brain lesions are able to predict later cognitive declines in people with RRMS. He also reads “Hunt for EBV Vaccine Gets a Boost From NIH”, from Ed Tobias' column, "The MS Wire." =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Follow us on social media!
Instagram - https://www.instagram.com/msnewstoday/
Twitter - https://twitter.com/MSNewsToday
Facebook - https://www.facebook.com/multiplesclerosisnewstoday/
Our #31DaysOfMS is shedding a light on the different ways our community does life with MS. Carolyn Hinds, one of the campaign’s contributors, chatted to us live about her own experience. This chat on all things MS was hosted by our very own Ally Macgregor. Listen to this conversation with Carolyn Hinds here and be sure to read her full story on our MS News Today website: https://bit.ly/39egrpD
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reports on how Canadians with multiple sclerosis said cannabis was highly effective in treating sleep issues, pain, stress, fatigue, and muscle spasms. He also reads “MS News That Caught My Eye Last Week: Cannabis, Keto Diet, Tysabri, MS Unknowns”, from Ed Tobias' column, "The MS Wire." =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article about a finding that could lead to treatment approaches that would instruct the immune system to "tolerate" the molecules wrongly targeted in MS. He also reads the latest article on our Expert Voices series, which focuses on the use of cannabis in people with multiple sclerosis. ===================================
Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ ===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how eating a ketogenic diet — low in carbohydrates and high in fats — led to less fatigue and depression for people with relapsing-remitting MS. He also reads “An Accessible Cruise With Family, Canes, and a Scooter Was a Breeze”, a column by Ed Tobias. ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, explains how Tysabri given every six weeks was found as effective as the standard dosing at stopping nervous system damage in RRMS patients. He also reads “Recovering My Self-esteem After Adapting to MS-related Incontinence”, from Beth Ullah's, regular column "Through the Looking Glass." =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article about how MS affects all aspects of life, from physical and mental health to relationships and hobbies, according to results from a U.K. online survey. He also reads "Remembering My First MS Symptom”, from Ed Tobias' column, "The MS Wire." =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge reads an article about the portable neuromodulation stimulator (PoNS) device that was approved by the FDA last year to help treat multiple sclerosis gait problems. He also reads “The MSer Who Lay in Bed for 2 Years and Can Now Walk Again”, a column by John Connor. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how blood levels of neurofilament light chain (NfL) helped predict disease progression in multiple sclerosis patients in a Phase 3 trial. He also reads “MS News That Caught My Eye Last Week: Bone Marrow Infusions, ATA188, Enhanced MRIs, Costs”, a column by Ed Tobias.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a blood test for the multiple sclerosis biomarker, neurofilament light chain, has been granted breakthrough device designation by the FDA. He also reads “The Tricks of Intermittent Catheterization When You’re in a Wheelchair” a column by John Connor. ===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a trial will test an antihistamine in combination with the diabetes medicine metformin as a way to repair the myelin sheath. He also reads the column by Ed Tobias, The MS Wire, “The High Cost of Living With MS”. ===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how four active progressive MS patients safely underwent a second harvesting and infusion of bone marrow cells in a safety, proof-of-concept trial. He also reads “Pain and Positivity: My Experience With Plasmapheresis,” a column by Beth Ullah.
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how a Phase 1/2 clinical trial has begun dosing with IMCY-0141, Imcyse’s targeted immunotherapy to slow progression of relapsing-remitting MS. He also reads “MS News That Caught My Eye Last Week: Deep Brain Stimulation, IMCY-0141, Foralumab, Vumerity,” a column by Ed Tobias. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Dr. Brandon Beaber is a board-certified neurologist with subspecialty training in multiple sclerosis and other immunological diseases of the nervous system. Dr. Beaber is also the author of Resilience in the Face of Multiple Sclerosis, where he shares examples of people who have made great strides and life pivots despite their degenerative conditions. Listen as they discuss why multiple sclerosis is affected by what you eat and how well you sleep, and why the resilience in Dr. Beaber patients inspired him to write a book.
Join the conversation on our MS forums: http://www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - http://www.instagram.com/msnewstoday/
Facebook - http://www.facebook.com/multiplesclerosisnewstoday
Twitter - http://www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
http://www.multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how Atara may open two Phase 3 clinical trials of ATA188, an immunotherapy targeting EBV-infected B-cells in non-active progressive MS patients. He also reads “Upon Reflection, I’m Determined to Seize the Day” from "The MS Wire," a column by Ed Tobias. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, explains how symptoms of Sjögren’s syndrome, including dry eyes and mouth, were observed among 16 people with multiple sclerosis. He also reads “‘Top Gear’: Unfortunately, I’m a Backward-leaning Jeremy Clarkson”, a column by John Connor. ===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how NVG-291, an experimental therapy to promote nervous system repair, has been well-tolerated in an ongoing Phase 1 study in healthy volunteers. He also reads the latest MS News Today’s Expert Voices article. In this instalment, Annie Brewster, MD, who also has MS, shares her tips on how to improve patient-provider relationships. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article about how the FDA has cleared eight more SPMS patients for treatment with foralumab nasal spray, under a special access program. He also reads “Crossing the Lemtrada Finish Line”, a column by Ed Tobias. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how treatment with evobrutinib appeared to safely and effectively reduced relapse rates in adults with relapsing MS for up to 2.5 years. He also reads “There’s No Such Thing as Perfect”, a column by Jamie Hughes. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how 75% of SPMS and PPMS patients in the CONSONANCE trial showed no evidence of disease progression after a year of Ocrevus treatment. He also reads “Old Friends, Broken Chairs, UTI Admissions, and Redemption”, a column by John Connor. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a questionnaire tailored for women with multiple sclerosis may help them talk to their doctor about their sexual health. He also reads “The Building Blocks of Becoming a Busy Bee”, a column by Beth Ullah. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how infection with the herpes simplex virus does not increase the risk of multiple sclerosis, according to a new analysis based on genetic data. He also reads the news article, “Artist With MS Finds Beauty, Individuality in MRI Brain Scans”.
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how the National Multiple Sclerosis Society detailed its Pathways to Cures Roadmap and ways to advance each pathway, with the goal to end MS. He also reads an article from MS News Today’s "Expert Voices", where Kassandra Munger explores research about the connection between vitamin D levels and MS, and shares her advice. ===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article on how researchers have discovered the key to bypassing the blood-brain barrier, which may lead to the development of more targeted MS treatments. He also reads “Dry Glaucomflecken and Other Healthcare Jokers” from Ed Tobias' column, "The MS Wire". ===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article about how cannabis-based medications could ease muscle spasms, decrease pain, and aid in sleep for people with MS. He also reads “The Heel that Won’t Heal”, by John Connor, from his column "Fall Down, Get Up Again".
=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, explains how a four-protein complex of the protein STAT5 could be involved in the development of MS-like autoimmune disease in mice.
He also reads “One Month of MS Awareness Isn’t Enough”, from Ed Tobias' column, "The MS Wire".
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Tim Coetzee is the Chief Advocacy, Services and Science Officer at the National Multiple Sclerosis Society. Tim leads all efforts focused on state and federal advocacy, marketing and communications, services and connection programs. He leads staff for the International Progressive MS Alliance – a global collaboration of MS Societies, scientists, the pharmaceutical industry and people with progressive MS. Join Jenn and Tim as they discuss why advocacy matters and the multiple ways the NMSS works positively for the MS community. Join the conversation on our MS forums: https://www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - https://www.instagram.com/msnewstoday/
Facebook - https://www.facebook.com/multiplesclerosisnewstoday
Twitter - https://www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
https://www.multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a study found no increased risks for women with MS or their babies after exposure to Ocrevus before or during pregnancy. He also reads an article about how autologous hematopoietic stem cell transplant, despite risks, may be a viable treatment option for some MS patients.
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how NVG-291 was deemed well tolerated, and is allowing enrolment of a second group of volunteers into its clinical trial.
He also reads “The Visible and Invisible Reflections of MS”, from Beth Ullah's column "Through the Looking Glass".
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how PIPE-307, a myelin-restoring treatment, was found safe in a Phase 1 clinical trial in 70 healthy adults. He also reads “31 Days of MS: My Diagnosis Helped Me Find My Purpose”, a story from our #31DaysOfMS initiative. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, explains how people with MS who drink alcohol on a daily basis may be at risk of losing nerve cells more quickly, according to a study. He also reads “MS News That Caught My Eye Last Week: Keto Diet, Milk and MS, Disability Progression, Neural Sleeve”, from Ed Tobias’ column, "The MS Wire". ===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how RRMS patients following a low-carb, high-fat diet for 6 months, showed better physical and mental health. He also reads “MS News That Caught My Eye Last Week: ‘Cog Fog’, Tolebrutinib, Ublituximab, Spinal Atrophy”, from Ed Tobias' column "The MS Wire". ===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how mice immunized with casein showed a nervous system inflammation and demyelination and how this may explain why MS symptoms can worsen with dairy. He also reads “31 Days of MS: Living with MS Has Launched My Radical Self-discovery”, a story from our #31DaysOfMS initiative. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, explains how administering NG-01 stem cell therapy directly into the spinal canal of patients with active progressive MS, reduced NfL levels.
Price also reads “MS News That Caught My Eye Last Week: aHSCT, Skin Cancer, Spasticity, NfL Blood Test”, from Ed Tobias' column, "The MS Wire".
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, explains how Masitinib significantly slows disability progression in adults with PPMS and non-active SPMS, according to new data. He also reads the news article, “31 Days of MS: My Daughter’s Diagnosis Has Brought Us Closer” and “31 Days of MS: A New Mindset Made Me Stronger”. Check out other ’31 Days of MS’ stories here. https://multiplesclerosisnewstoday.com/31-days-of-ms/
=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, covers how MS patients on Mavenclad are less likely to experience a disease relapse than those on other oral DMTs like Gilenya, Tecfidera, or Aubagio. He also reads “The Double-Edged Sword of Fatigue Medications”, from Beth Ullah's column "Through the Looking Glass". =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how a stem cell transplant can reduce relapse rates and ease disability in MS patients, especially those with milder symptoms. He also reads “The Captain and His No. 2”, from John Connor's regular column "Fall Down, Get Up Again".
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how S1P receptor modulators such as Mayzent and Gilenya may be associated with a greater likelihood of skin cancer. He also reads “The Supplements of Mice and Men”, from John Connor's regular column "Fall Down, Get Up Again".
Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, explains how levels of neurofilament light chain (NfL) in the blood can be used to predict the risk of future disease activity in people with MS. He also reads “The Furious Fire of Heat Sensitivity”, from Beth Ullah's column Through the Looking Glass.
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/ (edited)
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how the myelin sheath on specific neurons that suppress excess electric activity in other nerve cells may disrupt cognitive abilities of brain. And reads the column by Ed Tobias, The MS Wire, “MS News That Caught My Eye Last Week: Brain Atrophy, CD25, Neurodynamic Therapy, Anxiety”. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how study findings also suggest the chances of developing multiple sclerosis may be higher if you eat more cheese, poultry, sweets, fried foods. Price also reads the column by Ed Tobias, The MS Wire, “MS News That Caught My Eye Last Week: aHSCT, Myelin Vaccine, Bone Health, MIND Diet”. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how lesser feelings of anxiety were reported by MS patients who were more physical active, socially engaged, and made use of coping skills. Price also reads the column by Ed Tobias, MS Wire, “What Is Trigeminal Neuralgia in MS All About, Anyway?”. ===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Stuart Schlossman is an MS patient as well as president and founder of MS Views and News.MS Views and News (MSVN) is a Grassroots, Non-Profit 501C3, Nationally-based MS Patient Advocacy organization which provides educational programs, advocacy and resources to empower and enhance the quality of life, for the MS community. Join Jenn and Stuart as they discuss Stuart’s difficult journey toward a correct diagnosis and treatment plan, the evolution and success of MS Views and News, and what motivates Stuart to keep advocating for all in the greater MS community. Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how a large review study found poorer bone density (osteopenia) in almost half of MS patients evaluated and osteoporosis in about 17%. He also reads “The Big Blue Bag and a ‘Cast Away’ Bed”, a column by John Connor. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about Armand Thoinet. Armand was an active 19-year-old when he was diagnosed with relapsing-remitting MS. Since then, he manages his symptoms through endurance sports and advocacy. Price also reads “Don’t Worry and Take Your Time”, a column by Jamie Hughes. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how Pasithea Therapeutics, working with Hooke labs, wants to develop a "tolerizing" vaccine that will train the immune system and protect myelin; and reads the column by John Connor, Fall Down, Get Up Again, “At 64, I’m Surprised to Be Scrambling to Mount a Chariot”.
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how over half of MS patients treated with self-injectable therapies showed no evidence of disease activity after two years, a Turkish study found; he also reads “Don’t Worry and Take Your Time”, a column by Jamie Hughes.
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how multiple sclerosis is characterized by changes in methylation – a type of chemical modification in DNA – in immune cells called T-cells. Price also reads the article by Hawken Miller, “Tyler Campbell Traded Football Cleats for a Microphone”. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads about how MS patients with weak COVID-19 vaccine responses and receiving an anti-CD20 therapy are likely to respond favorably to the booster shot; Price also reads the column by Ed Tobias, MS Wire, “MS Hiker Laces Up Her Boots for Appalachian Trail”.
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the news article about a study in 24 RRMS patients linked meat consumption with changes to the immune system, gut microbiome, and metabolism relative to controls. Price also reads the column by Jamie Hughes, A Life in Letters, “Art for Our Sake”. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how the similarities between an Epstein-Barr (EBV) protein and GlialCAM protein may explain why EBV infection raises the risk of multiple sclerosis.
Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ ===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how vitamin D can influence immune system tolerance to certain proteins by changing how the DNA is packaged in dendritic cells, study reports.
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how mindfulness-based interventions helped people with MS cope with symptoms, according to a review of published studies. and also reads the column by Jamie Hughes, A Life in Letters, “No Wasted Moments”.
=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how people who do not drink alcohol are at increased risk of developing multiple sclerosis (MS), especially if they also are or were smokers. Price also reads reads the column by John Connor, Fall Down, Get Up Again, “This Week, MS Takes a Back Seat”. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how the FDA has approved Cortrophin Gel, an ACTH gel first introduced in the 1950s, for treating acute flare-ups in multiple sclerosis (MS); and reads “An Epstein-Barr Virus Primer for MS Patients”, a column by Ed Tobias.
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
In 2007, Tyler Campbell, son of Hall of Fame legend, Earl Campbell, was diagnosed with Multiple Sclerosis while playing football at San Diego State University. He continued to play football while keeping his diagnosis a secret. Unfortunately, shortly after his NFL Pro Day at San Diego, Tyler experienced a major setback that landed him in the hospital and in a wheelchair, unable to walk. After this episode, Tyler’s neurologist permanently sidelined his dreams of playing in the NFL.
However, Tyler believed that when one door closes, another opens. And it did. Tyler has been an instrumental figure in helping the greater MS community manage this disease. His candor is refreshing. Join Jenn and Tyler as they discuss Tyler’s early symptoms and diagnosis, how he adjusted to being a champion off the field, and how he continues to touch, move, and inspire through sharing the realities of life with MS. Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how new preclinical data continues to support the potential of Cyxone’s investigational plant-derived peptide T20K for the treatment of multiple sclerosis (MS). Price also reads the column by Jamie Hughes, A Life in Letters, “When Is a Wall Not Just a Wall?”. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a population-based study tied infectious mononucleosis (EBV) in childhood or adolescence to a roughly 2-to-3 times greater MS risk as adult. Also, Price Wooldridge, reads the column by John Connor, Fall Down, Get Up Again, “An Interview With My Primary Carer”. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how mice kept for two weeks at 10 C (50 F) showed lesser MS-like symptoms and inflammation than others, likely due to body's response to cold. Price also reads “Aquatic Therapy for Chronic Back Pain”, column by Ed Tobias. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how Owlytics’ provided scientific evidence that the smartwatch may be used as a measure of response to a treatment in a clinical trial. Plus, reads “Curing Headaches, Pain, and Stress, One Gizmo at a Time”, a column by Jamie Hughes. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses treatment with mesenchymal stem cells or MSCs in adults with active MS failed to significantly reduce brain inflammation, trial data show. Plus, reads the column by John Connor, Fall Down, Get Up Again, “There’s a New Primary Carer in Town”.
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses an early MRI measures of brain atrophy and serum NfL levels may accurately predict progression for relapsing forms of MS, a study suggests. Also, Price reads “More Answers About COVID-19 Vaccines and MS”, a column by Ed Tobias. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how younger RRMS patients (under 50) whose active disease fails to respond to DMT use might consider a patient-derived bone marrow transplant. Also, Price reads "“Kintsugi Reminds Me That Living With MS Isn’t Something to Hide”", a column by Jamie Hughes. ===================================
Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ ===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how Innodem and Novartis Canada are launching a clinical trial to evaluate biomarker eye-tracking technology for monitoring MS progression. Plus, Price reads “My Coffee Cup Runneth Over, Plus a Darned Interruption”, a column by John Connor. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how treatment with the anti-malaria medication hydroxychloroquine may help slow disability progression among people with PPMS. Price Wooldridge, reads the column by Jamie Hughes, A Life in Letters, “Just Put One Foot in Front of the Other”. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how people in Australia with multiple sclerosis (MS) and certain other medical conditions will have access to new and expanded medications — including Kesimpta — now listed on the Pharmaceutical Benefits Scheme (PBS). Plus, Price reads the column by Jamie Hughes, A Life in Letters, “Celebrity or Not, You Matter to the MS Community”.
=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article about how one year of Ocrevus (ocrelizumab) treatment does not increase the risk of a rare brain infection known as PML in people with MS, a study suggests. Plus, Price reads the column by John Connor, Fall Down, Get Up Again, “On the Healing Powers of THC”. ===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how treatment with evobrutinib reduced the size of inflammation-associated brain lesions in a Phase 2 trial in relapsing multiple sclerosis. Plus, Price reads the column by Jamie Hughes, A Life in Letters, “Being Prepared Can Help Us Succeed”. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Since 1985 Cyndi Zagieboylo has dedicated her life’s work to achieving National Multiple Sclerosis Society’s vision of a world free of MS. While serving on the Society's National Board of Directors as CEO and president, Cyndi serves on the Multiple Sclerosis International Federation CEO Advisory Group and Board of Trustees. A founding member of the International Progressive MS Alliance launched in 2013, Cyndi provides leadership as chair of the executive committee. The Alliance exists to expedite the development of therapies for progressive forms of MS by connecting global resources and experts.
Join the discussion as Jenn and Cyndi talk about the MS Society's many initiatives, resources, and programs. Cyndi has dedicated her life's work to achieving the National MS Society’s mission of curing MS while empowering people affected by MS to live their best lives.
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about how deep brain stimulation effectively reduces tremors in people with multiple sclerosis, according to a review study. Plus, Price Wooldridge, reads “Permanent Ink: My Tattoo Serves as an Important Reminder”, a column by Jamie Hughes. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses an article about how increasing the activity of the Myc gene can make myelin-repairing cells more efficient, a finding that may help advance MS treatments, a study says; and reads the column by John Connor, Fall Down, Get Up Again, “I’m Back in the Desert Without a Horse”.
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how Immunic Therapeutics has enrolled a patient in the Phase 2 clinical trial CALLIPER, testing oral IMU-838 for progressive MS; and reads the column by Ed Tobias, MS Wire, “Sun-seeking Finds Support in New Study.”
Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how TG Therapeutics is seeking FDA approval for ublituximab, its anti-CD20 monoclonal antibody infusion therapy for RRMS and SPMS with relapses; and reads the column by Jamie Hughes, A Life in Letters, “Listening to My Body as I Experiment With a New Diet”.
Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses an article about how NervGen will use Imeka's biomarker imaging technology to measure changes in brain and spinal cord in its Phase 1b/2 trials. Plus, Price reads the column by John Connor, Fall Down, Get Up Again, “Party on, Dude, but I’m Still Blaming the Dog!” =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how cognitive rehabilitation is an effective, low-risk and low-cost approach to treating cognitive problems of multiple sclerosis, study found; and reads the column by Ed Tobias, MS Wire, “I’m Back on the MS ‘Bladder Coaster’.”
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about how the first patient who completed GeNeuro’s ProTEct-MS Phase 2 trial has entered the study's extension, which will test higher doses of temelimab. Also, Price reads the column by Jamie Hughes, A Life in Letters, “You Don’t Always Need to Fix It”. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how mesenchymal stem cells can improve functional abilities and promote the remyelination in rodent models of MS, according to a meta-analysis. Plus, reads a column by John Connor, Fall Down, Get Up Again, “Groundhog Day, Groundhog Day, Groundhog Day, Groundhog Day.” Are you interested in learning more about multiple sclerosis? If so, please visit https://multiplesclerosisnewstoday.com
=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how in an unexpected discovery, scientists found that increasing the activity of PDGFRA reduces the production of myelin in the nervous system; and reads the column by Ed Tobias, MS Wire, “My Lemtrada Treatment, 5 Years Later.”
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a light-sensing protein present in the brain during fetal development may help explain why MS is more common among people born in spring. Plus, Price reads the column by Jamie Hughes, A Life in Letters, “Making the Most of Both Good Days and Bad”. Are you interested in learning more about multiple sclerosis? If so, please visit https://multiplesclerosisnewstoday.com
=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how treatment with Tecfidera led to fewer relapses in relapsing-remitting multiple sclerosis patients than Aubagio or injectable immunomodulators. Plus, Price reads the column by John Connor, Fall Down, Get Up Again, “It’s Just One of Those MS ‘Snow Days’.” =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how women with relapsing-remitting MS who stop fingolimod – sold as Gilenya – to conceive or in early pregnancy have a higher relapse risk. Also, Price reads “Once More, With Feeling: How Singing Can Benefit MS Patients”, a column by Jamie Hughes. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Jenn Powell speaks with identical twins with MS Tamara Kahn and Terry Hord. Meet identical twins Tamara Kahn and Terry Hord. Identical in every way, both were diagnosed with multiple sclerosis twenty plus years ago. These two amazingly close sisters created “TwinsCoast2Coast” to inspire, empower, support, and educate others about the challenges of MS while also showing the positives that have followed. From childhood and early signs of MS to college, marriage, children, and life, these two have navigated the highs and lows of MS together. Listen in as these sisters-turned-advocates share how their life’s mission is to help others find their own way. Check out their website at https://twinscoast2coast.com/ or follow them on Instagram @twinscoast2coast Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about a study that indicates how people who develop colorectal cancer are more likely to die from it if they have multiple sclerosis. Also, Price reads “MS and Fertility: Conflicts of the Heart and Mind”, a column by Beth Ullah. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the news article about how anti-CD20 antibody therapies that target B-cells are highly effective for reducing the risk of relapses in people with RRMS Also, Price reads “Thanks to a Wheelchair Mishap, I was ‘Busy Goin’ Nowhere’, a column by John Connor. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ ===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how oral fesoterodine fumarate tablets can reduce urinary disorders and improve quality of life for people with bladder impairment due to MS. Price also reads “Can Focusing on the Epstein-Barr Virus Help Researchers Fight MS?”, a column by Ed Tobias. =================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ ===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about how European Medicines Agency committee is recommending that Vumerity be approved for adults with relapsing-remitting multiple sclerosis in the EU; plus, Price reads the column by Jennifer Powell, Silver Linings, “When Loss Is Expected, How Do We Cope?”.
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how rim lesions, thought to indicate chronic brain inflammation, were found in about 4 of every 10 patients; declined with age, disease duration; and reads “Despite the Nerves, I Attended My First Family Gathering in 2 Years”, a column by John Connor.
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ ===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses an article about a class of molecules called positive allosteric modulators (PAMS) may be used to treat pain caused by nerve damage, a common symptom of MS. Price also reads a column by Ed Tobias, MS Wire, “I’m Sleeping Better These Days, but Why?”. =================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses an article on how bladder and bowel problems should be monitored regularly in MS patients to better adapt treatment plans and improve quality of life; plus, reads “Overcoming My Fear of Concerts With a Little Help From the Rolling Stones”, a column by Jennifer Powell.
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how chronic Inflammation in MS can be linked to specific brain cells, a recent study showed; and also reads “All Change Please, the Medical Equipment You’re Using Ends Here”, a column by John Connor.
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about how a study found MS and depression doubled patients' vascular disease risk over 10 years, and relative to controls greatly raised risk of death. Also, Price Wooldridge, reads “I’m Grateful for My COVID-19 Booster Shot”, a column by Ed Tobias. =================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ ===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge discusses an article about on how a study of immigrants with MS to Ontario, relative to residents with MS, found mood disorders and other comorbidities prevalent. Also, Price reads “Emotional and Physical Pain Are My Unwanted Sidekicks”, a column by Jennifer Powell. =================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ ===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how pro-inflammatory T helper 17 (Th17) immune cells directly interact with myelin-producing cells, promoting their damage and death. Price also reads “The Painful Tooth: My Weekend of Agony”, a column by John Connor. =================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how people who had been infected with the T. gondii parasite were 32% less likely to develop multiple sclerosis than those who had not. Price also reads the column by Ed Tobias, MS Wire, “Researchers Lower the Temperature to Try to Reduce MS Inflammation”. =================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Follow us on social media!
Instagram - https://www.instagram.com/msnewstoday/
Twitter - https://twitter.com/MSNewsToday
Facebook - https://www.facebook.com/multiplesclerosisnewstoday/
Have you ever wondered who's behind the MS News Today social media platforms? Ally Macgregor chats with Ed Tobias (@themswire) and Arelis Castillo (@msconstruedfashion) about their roles as the social media coordinators for MS News Today, their diagnosis stories, and how they use writing and fashion to connect with others in the MS community. You can watch this conversation again, here. Also, don't forget to check us out and follow us on social media!
InstagramLive here: https://www.instagram.com/tv/CVOsGokJ3fN/
Follow us on social media!
Instagram - https://www.instagram.com/msnewstoday/
Twitter - https://twitter.com/MSNewsToday
Facebook - https://www.facebook.com/multiplesclerosisnewstoday/
Have you ever wondered who's behind the MS News Today social media platforms? Ally Macgregor chats with two of the folks behind MS News Today’s online community, Rochelle (@thisisrochelle) and Desiree Lama (@thedeslama), about their diagnosis journeys, managing work with MS, and more. Hear about their MS journeys and how they like to spend their time when they're not online. ⠀ You can watch this conversation again, here. Also, don't forget to check us out and follow us on social media!
InstagramLive here: https://www.instagram.com/tv/CVOsGokJ3fN/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how patients who had six weeks of vibration training have showed better cognitive function and life quality, and lesser disability in a small study; and reads “As My Disease Progresses, I Choose to Grow”, a column by Jennifer Powell.
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how National MS Society investments support 29 training fellowships, early career awards, and research projects aligned with its Pathways to Cures Roadmap; and reads “He’s Fallen in the Water!”, a column by John Connor.
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
=====================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about a how a Phase 3 trial analysis showed ADS-5102 significantly increased walking speed in 21% MS patients with difficulties; further work stopped. Also, Price Wooldridge reads “It’s Flu Vaccine Time Again, So Here’s What You Need to Know”, a column by Ed Tobias. =================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Jenn Powell speaks with Director of Forums for SMA News Today, Kevin Schaefer Director of Forums for SMA News Today, Kevin Schaefer started at BioNews in 2017 as a columnist for SMA News Today, sharing his experiences as an adult with SMA Type 2. He eventually transitioned to a full-time role, helping build the company’s multimedia and forums divisions. Join Jenn and Kevin as they discuss commonalities between their diseases, how SMA and MS have changed their lives, and how having a sense of purpose has been pivotal in their ability to thrive with their diseases. Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about experiencing serious infections during adolescence and how this can be tied to an increased risk of developing multiple sclerosis later in life. Price also reads “When Restless Legs Syndrome Won’t Leave You Alone”, a column by Jennifer Powell. =================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ ===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about neurofilament light chain blood levels and cortical thinning on MRIs in recently diagnosed RRMS patients linked with poorer cognitive tests; and reads the column by John Connor, Fall Down, Get Up Again, “Down and Out in London Town!”.
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about BioNews Clinical, which aims to help clinical trials, essential to therapy, enroll people with rare and chronic disorders who want to participate. Price also reads “3 Things I Discovered at My 50th College Reunion”, a column by Ed Tobias. =================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about Belong.Life's, a new i-Belong app that allows health professionals, advocacy groups, pharmas and others to build and manage patient communities. He also reads “Next Time, Ask Me Why I Need and Accessible Parking Placard”, a column by Jennifer Powell. =================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how high levels of neurofilament light chain (NfL) protein combined with thinning of the retina can be a strong indicator of future disease activity; and reads the column by John Connor, Fall Down, Get Up Again, “Lockdown Blues: Well That Was a Close Shave!”.
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the news article, “FDA to Review ANI’s Request for Cortrophin Gel Use” and reads the column by Ed Tobias, MS Wire, “Amazon Care to Expand Company’s Reach Into Healthcare Services”.
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms_url&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how early high-efficacy disease modifying therapies (DMTs) are linked to better outcomes in patients with Relapsing-Remitting Multiple Sclerosis (RRMS) and reads “MS Doesn’t Get to Decide Whether We Are Enough”, a column by Jennifer Powell.
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms_url&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses Interferon Beta-1b, and it’s effectiveness and safety for older Multiple Sclerosis (MS) patients and reads the column by John Connor, Fall Down, Get Up Again, “I’ve Nothing Awful to Write About My MS This Week”.
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms_url&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses moderate-to-severe bowel problems found in 14.5% of people with Multiple Sclerosis (MS) and reads the column by Ed Tobias, MS Wire, “Humana’s Lawsuit Against Biogen Decries Ongoing ‘Seed and Sweep’ Schemes”.
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
=====================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses Landos Biopharma and Johns Hopkins School of Medicine partnering to advance a potential Multiple Sclerosos (MS) oral therapy & reads the column by Jennifer Powell, Silver Linings, “Are You Prepared for a Fall?”
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
=====================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses Multiple Sclerosis (MS) patients in the United States who may lack key insurance coverage and reads the column by John Connor, Fall Down, Get Up Again, “Be Warned: Another Column All About My MS and Me!”
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
=====================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how pain, fatigue, and anxiety are common in the first year after a Multiple Sclerosis (MS) diagnosis. Price also reads the column by Ed Tobias, MS Wire, “Are Generic and Brand-name Pills Created Equal?” =================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Join us as Jenn Powell speaks with multiple sclerosis patient and actor Damian Washington. Damian Washington has had MS for 6 years. But that doesn’t stop this actor, rapper, and self-described nerd from living his best life. Listen as Damian shares his MS experience, from first symptoms and diagnosis to learning to be his own advocate. Damian speaks candidly about how the landscape of clinical trials for MS need to address inclusivity, and how African American’s need equal representation. Warning: you may laugh. A lot. Damian Washington is actor from New York City and has appeared in over 30 commercials and voiceovers for brands like McDonalds, AT&T and Planet Fitness. His YouTube channel NoStressMS, about life with multiple sclerosis, has over 5,000 subscribers and won a 2020 WEGO Health Award for Best in Show. Viewers say the channel helps bring levity to the often-grim topic of autoimmune disease. Find out more about Damian Washington at: https://www.damianwashington.com/
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how probiotics are likely to be of help with relapsing-remitting multiple sclerosis (RRMS). He also reads “I Am Proud of the Disability I Once Feared”, a column by Jennifer Powell.
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how heat and variable temperatures have been found to increase risk of hospital visits for Multiple Sclerosis (MS) patients. Price Wooldridge also reads the column by John Connor, Fall Down, Get Up Again, “My Latest Trigeminal Neuralgia Attack Was Like a Knife Through the Molar”. =================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses factors linked to treatment adherence. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “Assessing My Pain, From Zero to 10”. =================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses the challenges of dating with MS. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Jennifer Powell, Silver Linings, “Choosing to Be Kind to Yourself Is as Easy as Making a Decision”. =================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses the prevalence of abuse among caregivers for those with MS. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by John Connor, Fall Down, Get Up Again, “This Fall Was a Real Eye-Opener.” =================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a phase 3 trial of Sativex, a cannabis extract, for MS spasticity. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “MS Paralympian Aims for a Bull’s-eye”. =================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a survey which finds high levels of dissatisfaction with quality of life, but satisfaction with healthcare. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Jennifer Powell, Silver Linings, “Get Out of Your Own Way: Growth at 36,000 Feet”. =====================================
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how the Swank and Wahls diets have both been found to improve fatigue and quality of life. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by John Connor, Fall Down, Get Up Again, “A Drizzly Summer Weekend and an Antibiotic Rejection”. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a collaboration which explores therapies for autoimmune diseases. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Jennifer Powell, Silver Linings, “Confessions of an MS Ableist: Change Begins with Me”. =================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a 5-year grant given to the Reeve Foundation’s Paralysis Resource Center. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “With MS, a New Pair of Shoes Makes a Big Difference”. =================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud =====================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses signaling proteins that have been seen to help promote myelin-making cells. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by John Connor, Fall Down, Get Up Again, “This Fall Was a Real Eye-Opener.” ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how gray matter in the hippocampus can help distinguish between two types of MS. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “I’m Trying a Different Medication, Myrbetriq, for My Urinary Issues.” ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how multivitamins reduce fatigue, improving quality of life in those with MS. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Jennifer Powell, Silver Linings, “To Ease My Suffering, I Had to Shift My Perspective, Not My Pain Levels”. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how strength of exhalations may predict MS severity. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “Do People with MS Need a 3rd Vaccine Shot?” ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Dr. Lewis has developed a specialty working with chronic diseases, with a particular focus on those diagnosed with Multiple Sclerosis. In this area, Dr. Lewis provides guidance, support and empathy around the feelings and reactions in response to being diagnosed, living with this diagnosis, relationship, workplace concerns and stressors, with particular emphasis on helping those diagnosed live with a disease characterized by its uncertainty and unpredictability. Dr. Gayle Lewis maintains a private practice in New York City, New York where she provides psychotherapy and psychoanalysis to individuals and couples. Find out more about Gayle Lewis at https://www.drgaylelewis.com/multiple-sclerosis-treatment
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how nerve tissue scarring may explain MS progression. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Jennifer Powell, Silver Linings, “MS Doesn’t Get to Decide Whether We Are Enough”. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how actively coping with daily stress of MS is tied to better quality of life. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Jessie Ace, Disabled to Enabled, “The Beginning of the End: A Reminder to #StayEnabled”. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how early high-efficacy therapies may be better to eliminate MS activity. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “Can Special Diets or Vitamin Supplements Improve My MS Symptoms?”. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how sleep deprivation may worsen memory in early MS. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Jennifer Powell, Silver Linings, “To Define My Reality With MS, I Choose Optimism”. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how early use of high efficacy DMTs favor lesser disability over time. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Jessie Ace, Disabled to Enabled, “Focusing on What I Can Do Rather Than What I Can’t”. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how the MIND diet may protect brain tissue in MS. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “Getting Something Off My Chest”. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how symptoms of MS are often apparent years before diagnosis. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Jennifer Powell, Silver Linings, “Management Through Meditation: Balance Can Happen With MS”. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how MS-related fatigue affects youngsters’ ability to function. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Jessie Ace, Disabled to Enabled, “Finding Comfort in Unlikely Places: TV Medical Dramas”. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how Brainstorm secured Nur-Own-associated patents in several markets. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “Could BTK Inhibitors Be the Next Big MS Treatment?” ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how younger age DMT use at early relapse may lessen future disability. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Jennifer Powell, Silver Linings, “Excising the Complaints in My Life Helps Me Manage MS”. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how scientists have discovered an enzyme needed for activating myelin repair. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Jessie Ace, Disabled to Enabled, “My Latest Obsession Help Me Combat the Uncertainties of MS”. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a stem-cell transplant trial in Minnesota which has enrolled its first patient. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “It’s Not a Crime to Ask for Help When You Need It”. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Jenn Powell speaks with physical therapist Gretchen Hawley, PhD. DPT. Join Jenn as she sits with Gretchen Hawley, a Doctor of Physical Therapy, and a Multiple Sclerosis Certified Specialist. Dr. Hawley utilizes the concept of neuroplasticity in her online MS wellness program, The MSing Link, to help her clients reduce fatigue, get stronger, improve their balance, and walk better. Listen in as Dr. Gretchen shares practical and helpful tips and suggestions on how everyone with MS can benefit from specifically catered physical therapy. Dr. Hawley has been a keynote speaker at several MS conferences, lectures frequently for MS support groups, and continues to keep herself up to date on the newest & best MS practices by attending the MS Consortium each year. Dr. Hawley resides in Buffalo with her dog, Finn. Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a computer-based training program which has captured cognitive gains in pediatric MS patients. Multiple Sclerosis News Today’s columnist, Jessie Ace reads for Jennifer Powell as she describes her journey with Rituxan and the side effects. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how DMTs are underutilized in younger patients. Multiple Sclerosis News Today’s columnist, Jessie Ace reads Jennifer Powell’s column where she describes her experiences of other people’s judgement around her disability. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses the prevalence of urinary problems in those with MS.
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “Using Cannabis to Treat Your MS? A Word of Caution”.
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
=====================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist Jenn Powell discusses how impaired social cognition may affect the well-being of RRMS patients.
https://multiplesclerosisnewstoday.com/news-posts/2021/06/07/impaired-social-cognition-rrms-may-affect-well-being/
Multiple Sclerosis News Today’s columnist, Jessie Ace reads Jennifer Powell’s column where she describes sailing as a young girl and how an event on a boat almost ended in disaster causing her to relate her SPMS with the incident.
https://multiplesclerosisnewstoday.com/silver-linings-a-column-by-jennifer-powell/2020/08/17/sailing-beyond-fear/
=====================================
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
=====================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how MS patients may apply for a mental health or addiction treatment scholarship.
https://multiplesclerosisnewstoday.com/news-posts/2021/06/02/red-songbird-foundation-jason-davis-scholarship-mental-health-addiction-treatment/
Multiple Sclerosis News Today’s columnist, Jessie Ace describes her experience of hiring a wheelchair after a recent flare to enjoy a day at the theme park.
https://multiplesclerosisnewstoday.com/disabled-to-enabled-a-column-by-jessie-ace/2021/06/18/hiring-a-wheelchair-to-enjoy-a-theme-park-day/
=====================================
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
=====================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how Walk MS Fundraising will be a ‘virtual experience’ in 2021. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “Don’t Let MS Stop You From Grandparenting”. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses an at-home brain program which is now available. Multiple Sclerosis News Today’s columnist, Jessie Ace describes how a recent flare caused challenges when she was asked to look after a dog. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how immersive virtual reality may improve treadmill gait training. Multiple Sclerosis News Today’s columnist, Jessie Ace reads for Jennifer Powell in this column where she discusses the role of positivity and the differences between positivity and reality. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses the first SPMS patient dosed with the nasal spray Foralumab. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “Sativex Study Reports Positive Results in People With MS”. =====================================
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how Vitamin D binding protein is a potential biomarker for MS. Multiple Sclerosis News Today’s columnist, Jessie Ace reads Jennifer Powells article where she discusses her new diagnosis and how this is linked to MS. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how ‘Stop Multiple Sclerosis’ Is the theme of World Brain Day. Multiple Sclerosis News Today’s columnist, Jessie Ace reads Jennifer Powell’s column and discusses the role meditation plays in managing her life with MS. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how male immune cells drive more severe MS. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “Was It Vertigo That Sent Me Tumbling the Other Day?” ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how MindMaze’s therapeutic games are opening to more MS, and other neurologic, patients. Multiple Sclerosis News Today’s columnist, Jessie Ace discusses how a Friday night film triggered a realization about her MS flares. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how perceptions of medication can predict MS treatment adherence, persistence. Multiple Sclerosis News Today’s columnist, Jessie Ace reads Jennifer Powell’s column where she describes how meaningful her dog, Abby, is to her whilst living with SPMS. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how minority research in MS is still lacking, but there is hope. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “Do High Antibody Levels Mean I’m Protected Against COVID-19?” ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Jenn Powell sits with Ed Tobias, senior patient columnist at MS News Today. Diagnosed with MS at age 32 in 1980, Ed writes the “The MS Wire” column for Multiple Sclerosis News Today. Join Jenn and Ed as they discuss living with secondary progressive MS later in life, disease-modifying-therapies, managing relationships, and more. Listen as Ed shares his broad spectrum of knowledge with the greater MS community. For information on Ed’s book, “We Are Not Drunk, We Have MS”, click here: https://www.amazon.com/Were-Not-Drunk-Have-sclerosis-ebook/dp/B08XPR2VFR/ref=sr_1_2?dchild=1&keywords=ed+tobias&qid=1619031772&s=books&sr=1-2
Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how fatigue prevalence remains high in MS patients. Multiple Sclerosis News Today’s columnist, Jessie Ace discusses how her neurologist gave her three options around treatments and she opted to change her diet. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how a new 3D model may help in promoting myelin and preventing its loss. Multiple Sclerosis News Today’s columnist, Jessie Ace talks through how it was hard at first being on her new diet, however, by changing her thinking she’s now growing to love it. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how lower intestinal fatty-acids may contribute to MS in women. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “45 Years and Counting, Even With MS”. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ ===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how a short film for Hispanic/Latinx MS patients improved perceptions and attitudes. Multiple Sclerosis News Today’s columnist, Jessie ace discusses how setting herself a goal of running 10 miles throughout April helped her gain control of an MS flare. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses the US patent issued for software that could make MRI scans safer. Multiple Sclerosis News Today’s columnist, Jessie Ace describes what she went through over the 5 weeks and how hypnotherapy helped her through it. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how oral DMT’s for RRMS in real-world use are seen to match trial findings. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “Should Dr. Google Help Guide Your Treatment?” ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how restless leg syndrome is more common in those with higher disability and spinal lesions. Multiple Sclerosis News Today’s columnist, Jessie Ace, discusses what hypnotherapy actually is and some of the myths around it that aren’t true. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
InstagramLive here: https://www.instagram.com/tv/CPhKJn5pWLa/
On May 30th, MS News Today columnist and podcaster Jenn Powell was live on Instagram in celebration of #WorldMSDay. She was joined by her sister, Laura Lewis. They discussed Jenn’s journey with multiple sclerosis and how important it is to have a good support system while managing the disease. Later on the conversation, Greg Sonn joined them. He is a dear friend of Jenn’s with a deep desire to help others with MS. He does so as he copes with the daily challenges of living with relapsing-remitting multiple sclerosis. Watch this Instagram Live here and let us know your thoughts!
Also, don’t forget to follow us on social media: Instagram - https://www.instagram.com/msnewstoday/
Twitter - https://twitter.com/MSNewsToday
Facebook - https://www.facebook.com/multiplesclerosisnewstoday/
=================================================== Join us on our MS Forums at: https://www.multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how combining different tests gives a clearer view of a patient’s quality of life. Multiple Sclerosis News Today’s columnist, Jessie Ace discusses what she experienced in her first session of hypnotherapy and what she learned. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a grant by the MS society of Canada to support AI in predicting disease course. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads “How Do You Define an MS Cure?”, a column by Ed Tobias where he discusses a question that he gets lot: “Why aren't researchers doing more to find a cure for MS?". ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how mindfulness helps to reduce depression and fatigue in MS patients. Also, columnist Jessie Ace describes how after a suggestion from a friend decided to try a new type of therapy. =====================================
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how one-third of those in the UK with MS keep their status a secret. Multiple Sclerosis News Today’s columnist, Jessie Ace describes how Marisa Peer’s guided meditation helped manage anxiety around her MS flare. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses the 2021 Dystel prize for innovation in multiple sclerosis. Also, Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “When an Unexpected Driving Test Causes a Pseudo-flare”. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
=====================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Dr. Beier is a rehabilitation neuropsychologist in the Department of Physical Medicine and Rehabilitation at Johns Hopkins. She is a nationally recognized expert on the mood and cognition symptoms common to multiple sclerosis. Join Jenn as she speaks with Meghan about specific skills and techniques to improve quality of life, reduce unwanted emotions, enhance brain skills, and reduce fears around memory lapses or illness uncertainty associated with multiple sclerosis. Meghan is also the CEO and founder of findempathie.com, a website helping people with medical conditions find a mental health provider who understands their diagnosis. Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how WNT9B genetic variant linked to increased relapse risk. Also, Jessie Ace reads Jennifer Powell’s article which describes how important laughter and a sense of humor is in coping with an unpredictable disease like MS. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how MS has 3 distinct subtypes as shown in AI reports. Multiple Sclerosis News Today’s columnist, Jessie Ace reads Jennifer Powell’s column about why Jennifer uses the words ‘I am fine’ to protect the people around her from knowing the truth. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how retinal layer thickness may predict MS progression. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “Efficacy of Pfizer-BioNTech Covid-19 Vaccine Varies by DMS, Study Finds”. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how rates of MS seem to rise with nations’ prosperity. Multiple Sclerosis News Today’s columnist, Jessie Ace reads Jennifer Powell’s column as she discusses the role music plays in managing her MS. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses FDA approval for Wise’s digital anxiety management therapy. Also, columnist Jessie Ace reads a column by Jennifer Powell where she describes how her new role of being the caregiver in her relationship makes her feel. =====================================
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how a machine learning of walking patterns could help predict progression in those with MS. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “This New Tool Can Help You Choose Which DMT to Use”. To try the DMT Choice Tool go to: https://clinicspeak.com/dmt/#/ =====================================
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses the FDA approval of the PoNS device which helps gait in adults with MS. Multiple Sclerosis News Today’s columnist, Jessie Ace reads a column by Jenn Powell where she describes the power of thoughts and how they build the decisions we make. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a phase 2 clinical trial in which NurOwn’s cell therapy for progressive MS has been found safe and effective. Also, Multiple Sclerosis News Today’s columnist, Jessie Ace reads Jenn Powell’s column where she discusses how to manifest change with secondary progressive multiple sclerosis. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how early MRI findings may predict disease worsening in children with MS. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “What Do the Oscars and our COVID-19 Response Have in Common?” ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a mega-trial in the UK to test multiple MS therapies. Multiple Sclerosis News Today’s columnist, Jessie Ace reads a column by Jen Powell’s discussing the importance of our own self-care. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how Pilates helps men with MS gain balance. Also, columnist Jessie Ace reads from Jennifer Powell’s column, Silver Linings about the new drug, Zeposia, and what this could mean for the MS community. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how certain factors worsen outcomes in MS patients with Covid-19. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads “Let’s Treat Older MS Patients with More Respect”, a column by Ed Tobias. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Jenn Powell sits with Kathy Costello, MS, ANP-BC, MSCN, the Vice President of programs with Can Do MS. Can Do MS is a non-profit organization which offers health and wellness education programs to help those living with MS thrive. Prior to joining the team at Can Do MS, Kathy was the Associate Vice President of Healthcare Access for the National MS Society where she led the organization efforts to expand and provide educational opportunities for the MS workforce. Kathy is also a nurse practitioner with over 20 years in academic medicine focused on the care of people living with MS. Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday
Twitter - www.twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how Pack Health with the support of the NMSS, is bringing a coaching platform to the MS community. Multiple Sclerosis News Today’s columnist, Jessie Ace talks about starting to run again after her latest MS exacerbation and the power she feels from running. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how Covid-19 concerns affected how patients managed their MS. Multiple Sclerosis News Today’s columnist, Jessie Ace discusses how she helped find MS voices to share their MS experiences for the 31 days of MS campaign, an initiative by Multiple Sclerosis News Today to raise awareness of MS. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a foot drop device which won the Innovation Challenge prize. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads “My MS Likes It Hot, and Florida’s Just the Place”, a column by Ed Tobias. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ ===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how minorities with MS voice interest in clinical trials, but express concerns. Multiple Sclerosis News Today’s columnist, Jessie Ace talks through her recent MS exacerbation in which she found mental strength and clarity. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how vitamin D supplements (at a preclinical stage) prevented MS in mice. Multiple Sclerosis News Today’s columnist, Jessie Ace describes how a recent MS exacerbation initiated a strange behavior to gain more certainty. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how Emerald Health is preparing for phase 2 trial of EHP-101 for relapsing forms of MS. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads “An Update on My Lemtrada Journey 3 Years After Round 2”, a column by Ed Tobias. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how rising temperatures could lead to greater care needs for those with MS. Also, Multiple Sclerosis News Today’s columnist, Jessie Ace discusses the role gratitude plays in her MS journey and how you can use it to lessen your anxiety. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a NMSS partnership which targets autoimmune disease research. Multiple Sclerosis News Today’s columnist, Jessie Ace discusses how MS makes her feel part of a secret club of a minority who understand. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a new digital music therapy for those with MS. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads “Why We Still Need to Wear Masks, Socially Distance, and Wash Our Hands”, a column by Ed Tobias. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how physical inactivity and smoking are linked to patient fatigue in those with MS. Multiple Sclerosis News Today’s columnist, Jessie Ace describes how her life has been impacted by a VR headset and explores how this technology might be used in the future of our healthcare. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses the 2020 recipient of the Barancik prize for innovation. Multiple Sclerosis News Today’s columnist, Jessie Ace reads a column from Jenn Powell about the new Myeliviz imaging agent and what this means for people with MS. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how an AI-powered robotic glove may help improve hand grip strength in those with MS. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “Ocrevus and PML: Should We Be Worried?” ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a Dutch study linking diet to higher quality of life in those with MS. Multiple Sclerosis News Today’s columnist, Jessie Ace, reads from Jenn Powell’s column and speaks about how superbugs are becoming too powerful for antibiotics. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses two biomarkers found to predict MS onset in people with optic neuritis. Multiple Sclerosis News Today’s columnist, Jessie Ace, talks about a show she watched and how disability was perceived by strangers. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how Pipeline raised $80M to pursue potential myelin restoring therapy. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “The MS Immune System: Suppressed, Compromised, or What?” ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Jenn Powell sits with Greg, a friend with relapsing-remitting multiple sclerosis. Join them as they discuss managing the physical and psychosocial aspects of this disease, as well as the everyday challenges of living with multiple sclerosis. Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram – www.instagram.com/msnewstoday
Facebook – www.instagram.com/msnewstoday/
Twitter – www.instagram.com/msnewstoday/
For more news on Multiple Sclerosis visit: www.instagram.com/msnewstoday/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how early life trauma affects MS development in mice. Multiple Sclerosis News Today’s columnist, Jessie Ace, describes having a new symptom and knowing when to call your MS nurse. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ ===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how the Progressive MS Alliance wants changes to trials to better realize treatments. Multiple Sclerosis News Today’s columnist, Jessie Ace reads Jennifer Powell’s column about how she is coping going through life battling with sickness and sadness. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how new spinal cord lesions can be evident in stable MS patients. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “My 2nd COVID-19 Vaccine Shot Caused No Harsh Side Effects”. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how telemedicine has been found to be effective during Italy’s Covid-19 lockdown. Multiple Sclerosis News Today’s columnist, Jessie Ace reads a column by Jenn Powell’s about how she is accepting that her illness makes her feel rare. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a protein-targeting therapy found to lessen inflammation in preclinical studies. Multiple Sclerosis News Today’s columnist Jessie Ace reads a column by Jennifer Powell describes her experiences of traveling with Secondary Progressive Multiple sclerosis and the problems she’s faced because of her disability. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a European project which uses artificial intelligence to help improve patient care. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “I Had a Stupid, Scary Spill, but It Could Have Been Much Worse”. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how the potential for stem cells to repair myelin is the focus of a team at the University Toronto. Multiple Sclerosis News Today’s columnist, Jessie Ace, reads an article by Jennifer Powell where she describes how she has found the importance of allowing her mind to work through grief and why you need to let go. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how NfL mirrors some life quality aspects felt by patients. Multiple Sclerosis News Today’s columnist Jessie Ace reads a column by Jennifer Powell where she describes what painsomnia is and how this affects her day-to-day life. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how age is found to be a main driver of MS disability. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “The Disturbing Trend of Caregiver Abuse in the MS Community”. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses Innodem’s new way of diagnosing and tracking MS through eye movement. Multiple Sclerosis News Today's columnist Jessie Ace reads Jennifer Powell column where she discusses how she manages people’s expectations when they tell her about a possible ‘MS cure’. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ ===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how stem cell treatment is most effective for RRMS MS patients. Multiple Sclerosis News Today’s columnist Jessie Ace, reads Jennifer Powell column where she describes how her last 10 years have been affected by a diagnosis and how she chooses to see the positives. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ ===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses the agenda for ACTRIMS 2021. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “Are You Having Trouble Paying for Your MS Medications?”. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Jenn Powell sits with world-renowned neurologist, Tanuja Chitnis, MD, FAAN. Join the conversation as they discuss the longitudinal CLIMB study, pediatrics and MS, in addition to the cellular and psychosocial aspects of multiple sclerosis. Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - http://www.instagram.com/msnewstoday/
Facebook - http://www.facebook.com/multiplesclerosisnewstoday
Twitter - http://twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
http://www.multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how low levels of fatty acid may affect the immune system of patients with MS. Multiple Sclerosis News Today’s columnist Jessie Ace reads an article by Jennifer Powell where she discusses how medications are being promoted through TV advertising and how this affected her decision about switching medications. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist Jenn Powell, discusses a new study assessing the effects of Tysabri on cognitive fatigue. Multiple Sclerosis News Today’s columnist Jessie Ace reads an article by Jennifer Powell where she discusses how meditation manages the symptoms of secondary progressive MS. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how brain changes in Relapsing MS has been found to follow a pattern. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “The First COVID-19 Shot Is Finally in My Arm”. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how Silo Pharma is set to explore ways of making MS therapies more effective. Multiple Sclerosis News Today’s columnist, Jessie Ace discusses how the language she told herself changed the trajectory of her life. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how sexual dysfunction is common in men with MS. Also, Multiple Sclerosis News Today’s columnist Jessie Ace talks about managing fatigue. If you’re struggling with fatigue listen to Jessie Ace’s one trick that she swears by for managing her fatigue and accomplishing tasks. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a public-private partnership to assess the therapy potential and effects of CBD. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “Upper Body Health Also Is Important for People with MS”. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses Helius and their delivery of information to the FDA about the PoNS device. Multiple Sclerosis News Today’s columnist, Jessie Ace discusses the 5 steps you can take to reduce the common blue feelings one can get at the start of the year. Warning, bad jokes inside! ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a BioNTech vaccine that treats MS in mice without dampening the immune system. Jessie Ace discusses how she has learned to appreciate her progress with illustration and finding a way to be self-employed that works for her and around her MS. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how past long term DMT use tapers risk of current MS progression. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “Don’t Jump to Conclusions Over a Breakthrough MS Vaccine Just Yet”. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist Jenn Powell, discusses how target tissue of immune attacks is too often ignored in research. Multiple Sclerosis News Today’s columnist Jessie Ace, discusses her views on resolutions and why she prefers to set goals and targets instead of make resolutions. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how obesity and a higher BMI are linked to a greater risk of developing MS and harmful autoimmune activity. Multiple Sclerosis News Today's columnist, Jessie Ace, talks through the ideas around why we do the things we do and why do we spend what little precious energy we have pleasing others? ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how less sunlight may mean that those with MS are at risk for more relapses. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “Car Repairs Aren’t Easy When You Have MS”. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ ===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
In the first episode of "The Multiple Sclerosis Podcast with Jenn Powell", Jenn talks with Jon Strum, host of the podcast, RealTalkMS. Jon shares his own experience as a caretaker for his wife who was diagnosed with progressive MS, in addition to what he sees as hope for those living with the disease. Join the conversation on our MS forums: http://www.multiplesclerosisnewstoday.com/forums/
Follow us on social media:
Instagram - https://www.instagram.com/msnewstoday/
Facebook - https://www.facebook.com/multiplesclerosisnewstoday
Twitter - https://twitter.com/msnewstoday
For more news on Multiple Sclerosis visit:
https://multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses the recipient of the 2020 Sobek prize given to a leading physician-scientist for work in the field multiple sclerosis. Plus, Multiple Sclerosis News Today’s columnist Jessie Ace discusses a tip she discovered for lessening her fatigue by having a tech-free day. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ ===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how mentally overestimating motor tasks may cause fatigue in those with MS. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace discusses how hard it is to talk about your illness and others approach asking you about your diagnosis. Is there a ‘right’ way to tell them? ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how children of diabetic mothers may be at increased risk of developing MS. Plus, Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads Jessie Ace’s column, DISabled to ENabled, on the things people say when you tell them about your multiple sclerosis diagnosis. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how primary headaches are more prevalent in patients with MS. Plus, Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads Jessie Ace’s column, DISabled to ENabled, on the things people say when you tell them about your multiple sclerosis diagnosis. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud =====================================
Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ ===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses the FDA approval of a shorter infusion time for the MS therapy Ocrevus. Plus, Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads Jessie Ace’s column, DISabled to ENabled, on the things people say when you tell them about your multiple sclerosis diagnosis. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud =====================================
Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ ===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a study which seeks to better understand how MS affects memory. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “Can Amazon Lower Healthcare Costs?” ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how children with MS recover better from relapses than adults. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, Jessie Ace talks through the six main types of fatigue and how it affects us. Jessie talks through what she learned from an MS nurse at an MS Society seminar in 2019. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how stem cell transplant reduces relapses and disability in RRMS. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, Jessie Ace talks through the advantages and disadvantages of turning to an online community for support, plus what to watch out for when joining online groups. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a study in which MS has a greater impact on women’s physical activity. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the Ed Tobias column, MS Wire, “Will Reduced Treatment Time Keep Ocrevus Competitive?”. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how adolescents with MS tend to have lower levels of physical fitness. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, talks through her experiences of taking Rebif and gives tips on how to make your injections easier that she learned too late. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a pilot study in which an MS-specific cognitive rehabilitation tool shows promise. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, Jessie Ace talks about the surprising reason we feel uncertainty and it’s weird importance. Plus, learn how it occurs and how we can reduce it. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a review study which examines factors that affect MS patients’ quality of life. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses the high prevalence of primary headaches in Multiple Sclerosis patients. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud =====================================
Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ ===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how chronic lesion expansion in RRMS contributes to disease progression, according to a study. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, discusses the annoying things that can happen for a person with MS at the end of the year. On top of a time that is already cold, and stressful, how do you also manage other people’s expectations? ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how virtual-reality based rehabilitation may improve upper limb function in MS patients. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, describes how the changing clocks cause her great confusion and how the seasons affect her MS symptoms. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a Canadian study which found that MS patients are at higher risk for bladder cancer, but not breast or colorectal cancer. Plus, Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads Jessie Ace’s column, DISabled to ENabled, on the things people say when you tell them about your multiple sclerosis diagnosis. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a new $100M program aimed to improve diversity in clinical trials. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, talks through the main mental health points that doctors don’t tell you after your diagnosis, such as going through the five stages of grief. =====================================
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how tablet-based video games could help measure cognitive impairment in those with MS. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, describes how MS symptoms feeling like they’re getting worse could actually be caused by internal conflict in your brain causing you more stress. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how smartphone typing patterns may be a tool for monitoring MS progression. Plus, Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the Ed Tobias column, MS Wire, “Can I Get a COVID-19 Vaccine If I Have MS?”. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ ===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a recent study which found MS patients with depression symptoms to have more difficulty multitasking. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, discusses a common symptom for all of us at one point or another, ‘bloating’. She outlines the possible reasons why we could be bloated and the one surprising reason for bloating you may not have heard of before. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud =====================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how a new automated platform may help test cognitive function in those with MS. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, talks about her unique hack that she developed leading to a better experience while visiting her doctor. She describes how not remembering her medical history led to her being a published author. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ ===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how disease progression differs more across MS type than sex of patients, according to a study. Plus, Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the Ed Tobias column, MS Wire, “There Is No Magic Pill for MS Fatigue”. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ ===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses MS Trust funding that will help improve patient support during the pandemic. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, discusses the 3 main things people say when you tell them about your diagnosis, why they likely say these things and an alternative response that would be more helpful to the person with MS. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud =====================================
Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ ===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses that, according to an MS Society expert, bone marrow transplants are most successful for younger patients. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, reads from her article entitled Managing expectations on your wedding day. Jessie Ace discusses the age-old question people ask of when are you having kids, how this question could be damaging and how to manage this expectation if you’re asked. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. http://ChangesInRMS.com ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ ===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses neurofilament light levels at first MS event can predict long-term brain atrophy. Plus, Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a tablet-based video game which could help measure cognitive impairment in Multiple Sclerosis (MS). ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. http://ChangesInRMS.com ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a non-invasive imaging technique which reveals ibudilast’s neuroprotective effect. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, reads from her article entitled You look ok to me. After a recent episode in London with a bouncer, Jessie Ace talks through what happened when she was stopped from using the disabled toilet in a London bar. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. http://ChangesInRMS.com ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a grant given by Israel to Owlytics to develop a wearable AI device in hopes of improving MS care. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, reads from her article entitled 3 Things to Do If You’re Freaked Out by Blood Tests. Blood tests can be tough, especially if they make you highly anxious. Jessie Ace shares her advice on how you can make them easier. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses findings suggesting possible DMT risk for MS patients over age 45. Plus, Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the Ed Tobias column, MS Wire, on travel during Covid-19: Should we stay or should we go? ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a study in which myelin is restored on regenerated optic nerve fibers of mice. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, talks about how receiving a NEDA (no evidence of disease activity) from a recent MRI makes her feel like a fraud. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses the Innovation Challenge sponsored by Lyfebulb and Bristol Myers Squibb. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, shares the advice from her and her husband that is often missed by medical professionals. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. http://ChangesInRMS.com =====================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses the discovery of new immune cells that may help treat Multiple Sclerosis Plus, Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article written by Ed Tobias, the discusses how the Multiple Sclerosis International Federation (MSIF) is issuing new recommendations to protect against COVID19. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a recent study suggesting that there is no association between the skin condition Vitiligo and MS.
Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, shows you how to practice visualization going on a holiday without even leaving your house, along with more practical applications.
===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how an early study shows that VX-765 therapy, given through the nose, limits MS progression. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, discusses how she fought past her anxiety to create a resource to help others diagnosed with illnesses like MS, despite challenges. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. http://ChangesInRMS.com =====================================
Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ ===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses the results of a survey suggesting that the majority of MS patients in the U.S. report mistreatment by caregivers. Plus, Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article written by Ed Tobias entitled aHSCT Gets a Boost in US With the National Multiple Sclerosis Society recommendation. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses risk factors for unemployment in people with MS. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, reads from her DISabled to ENabled column entitled We Are What We Tell Ourselves. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. http://ChangesInRMS.com ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses metabolic changes relating to MS onset and progression. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, reads from her DISabled to ENabled column entitled Do You Speak Candidly with Your Partner about Your Diagnosis? ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how almost half of MS patients in the US surveyed, report using cannabis for nerve pain and sleep. Plus, Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article written by Ed Tobias entitled MS News That Caught My Eye Last Week: Caregivers, VX-765 ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. http://ChangesInRMS.com ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how a recent study found that hypertension is quite common among MS patients in the United States. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, reads from her DISabled to ENabled column entitled 3 Techniques to Help You Overcome Anxiety and Stress. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how iron deficiency may be linked to depression and poorer quality of life in those with MS. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, reads from her DISabled to ENabled column entitled April Fools’ Day Joke That Wasn’t Very Funny ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. http://ChangesInRMS.com ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses health-related quality of life in people with multiple sclerosis Plus, Multiple Sclerosis News Today’s columnist and forums moderator, Ed Tobias, reports on differences between how physicians in the U.S. and Britain are treating patients during the COVID-19 pandemic. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how, according to a French study, MS patients have a higher burden of mental disorders. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, reads from her DISabled to ENabled column entitled 5 Hacks For Keeping Cool without An A/C. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. http://ChangesInRMS.com ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses the release of medical cannabis lozenges by Surterra Texas, to patients with Multiple Sclerosis. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, reads from her DISabled to ENabled column entitled What Does 'ENabled Warrior' Mean to You? ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses the worldwide prevalence of MS at 2.8 million. Plus, Multiple Sclerosis News Today’s columnist and forums moderator, Ed Tobias, reports on what the U.S. government is doing, and what it’s not doing enough of, during National Disability Employment Awareness Month. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses the recent $2.3 million awarded by the NIH to a bioengineer, to advance diagnosis and treatment of autoimmune diseases. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, reads from her DISabled to ENabled column entitled How Much Caffeine Are You Consuming? ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. http://ChangesInRMS.com ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how fatigue tops survey about relapsing MS symptoms. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, reads from her DISabled to ENabled column entitled A Simple Hack To Access Better Treatment by Doctors. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how children with MS have cognitive problems which persist into adulthood. Plus, Multiple Sclerosis News Today’s columnist and forums moderator, Ed Tobias, reports on a study about tattoos, sweat and MS. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how pediatric MS patients may do better on intravenous DMTs. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, reads from her DISabled to ENabled column entitled How to Maximize Productivity While Working from Home. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how high-efficacy DMT’s are more effective in slowing retinal atrophy in those patients with RRMS. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, reads from her DISabled to ENabled column entitled How to Cope and Thrive During a Challenging Time. =====================================
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. http://ChangesInRMS.com ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses the presence of lesions first seen in the G.I. tract of mouse models with MS. Plus, Multiple Sclerosis News Today’s columnist and forums moderator, Ed Tobias, reports on a new Food and Drug Administration recommendation about amalgam dental fillings. ===================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. http://ChangesInRMS.com ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how MS relapses during pregnancy are more likely on high-efficiency DMT’s. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, reads from her DISabled to ENabled column entitled Tips for Traveling the World From the Comfort of a Couch.
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. http://ChangesInRMS.com
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how longer DMT exposure may delay disease progression in MS. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, reads from her DISabled to ENabled column entitled 5 Activities You Can Do At Home For Free During A Flare Or A Low Energy Day.
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses the pandemic’s minimal emotional impact on people with progressive MS. Plus, Multiple Sclerosis News Today’s columnist and forums moderator, Ed Tobias, considers the importance of a patient-doctor risk-benefit analysis before deciding on a treatment.
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how MS patients who interact with health information are more likely to adopt a healthy lifestyle. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, reads from her DISabled to ENabled column entitled Many MS Symptoms Are Invisible.
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses targeting B-cells in Cerebral Spinal Fluid, may lead to more effective therapies for MS. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, reads from her DISabled to ENabled column entitled Using Social Media To Challenge Perceptions About Disability.
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. http://ChangesInRMS.com ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how migraines are present in 30% of MS patients. Plus, Multiple Sclerosis News Today’s columnist and forums moderator, Ed Tobias, looks at the impact of MS on the financial well-being of people living with the disease.
=====================================
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
=====================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how gut bacteria, working in concert, may promote MS. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, reads from her DISabled to ENabled column entitled Reflecting On What Makes Me Rare
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how youthful obesity may account for 14% of all MS cases by 2035. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, reads from her DISabled to ENabled column entitled What To Expect From An MRI Scanner.
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. http://ChangesInRMS.com ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses SomaChemical’s recently acquired right to the patented formula that aims to ease and eliminate neurodegeneration in people with MS. Plus, Multiple Sclerosis News Today’s columnist and forums moderator, Ed Tobias, reports on why health officials say getting a flu shot this year is more important than ever.
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how immune T-cells can trigger early MS inflammation. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, reads from her DISabled to Enabled column entitled 5 Ways To Manage Your Fatigue.
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. http://ChangesInRMS.com
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how MS patients with cooling vests show significant exercise gains. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, reads from her DISabled to Enabled column entitled You Can’t Park There, You’re Not Disabled.
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how MRI changes can reflect function in progressive Multiple Sclerosis. Plus, Multiple Sclerosis News Today’s columnist and forums moderator, Ed Tobias, discusses a new Amazon wearable device designed to help you stay healthy.
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how a mechanism controlling remyelination may have MS therapy implications. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, reads from her DISabled to Enabled column entitled One Way To Be More Successful with MS.
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
=====================================
Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how genetic variance may contribute to the increased levels of antibodies against proteins of the Epstein-Barr virus. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, reads from her DISabled to Enabled column entitled 5 Myths About MS That Are Actually Not True.
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how paramagnetic rim lesions are showing promise as a diagnostic marker of MS. Plus, Multiple Sclerosis News Today’s columnist and forums moderator, Ed Tobias, reports on a lawsuit against the maker of Copaxone and says there are two sides to the coin.
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. http://ChangesInRMS.com ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
===================================== To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how children with MS may have more relapses, but recover more fully.
Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, reads from her column, DISabled to ENabled, entitled How I Lost Control of My Body.
=====================================
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
ChangesInRMS.com
=====================================
Are you interested in learning more about multiple sclerosis? If so, please visit: multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
multiplesclerosisnewstoday.com/forums/
MS
MS News Today
Multiple Sclerosis
Living with MS
Mayzent
Relapsing MS
DISabled to ENabled
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses Mylan’s launch of a Tecfidera generic in the United States.
Plus, Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads Jessie Ace’s column, DISabled to ENabled, on the things people say when you tell them about your multiple sclerosis diagnosis.
=====================================
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info: ChangesInRMS.com
=====================================
Are you interested in learning more about multiple sclerosis? If so, please visit: multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
multiplesclerosisnewstoday.com/forums/
MS News Today columnist and forums moderator Ed Tobias shares his opinion of the Bioness L300 Go Functional Electrical Stimulator. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today columnist, Jenn Powell discusses how inflammation may drive nerve damage in those with early Multiple Sclerosis. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
MS News Today columnist and forums moderator Ed Tobias reports on a potential MS treatment that stimulates the brain by passing a mild electrical current through the tongue. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today columnist, Jenn Powell discusses the new patent filing for QuadraMune, and how it relates to the potential in aiding memory in those with MS. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
MS News Today columnist and forums moderator Ed Tobias comes face to face with disability when he watches the movie Crip Camp. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today columnist, Jenn Powell discusses how regular exercise helps preserve key brain areas in those with MS. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
MS News Today columnist and forums moderator Ed Tobias reports on a study of two people with COVID-19 who were also being treated with Lemtrada. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today columnist, Jenn Powell discusses how those with MS are more likely to need leave from work than the general public. Are you interested in learning more about Multiple Sclerosis? If so, please visit
https://multiplesclerosisnewstoday.com/
MS News Today columnist and forums moderator Ed Tobias talks about his MS stress reliever, Joey his Cocker Spaniel. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today columnist, Jenn Powell discusses Banner Life Sciences announcement that Bafiertam will become available to those in the United States with relapsing forms of Multiple Sclerosis. Are you interested in learning more about Multiple Sclerosis? If so, please visit
https://multiplesclerosisnewstoday.com/
MS News Today columnist and forums moderator Ed Tobias reports on recent research about preventing falls. Does coaching help? Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today columnist, Jenn Powell talks about a new clinical trial to assess the potential benefits of cannabis for spasticity in those with Multiple Sclerosis.
Are you interested in learning more about Multiple Sclerosis? If so, please visit
https://multiplesclerosisnewstoday.com/
MS News Today columnist and forums moderator Ed Tobias shares his feelings about Disability Pride Month. Hint: It’s not for him. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today columnist, Jenn Powell discusses how higher BMI in teenagers raises the risk of Multiple Sclerosis in young men. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
MS News Today columnist and forums moderator Ed Tobias reports on a decision delaying the availability of Mayzent in the U.K.
Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today columnist, Jenn Powell discusses how anxiety and depression increase the potential of relapse in those with Relapsing Remitting Multiple Sclerosis. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
MS News Today columnist and forums moderator Ed Tobias reports on the latest COVID-19 recommendations from the MS International Federation. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today columnist, Jenn Powell discusses the prevalence of depression in those with Multiple Sclerosis. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
MS News Today columnist and forums moderator Ed Tobias tells you about two new smartphone apps for people with MS. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today columnist, Jenn Powell discusses Autobahn Therapeutics aim to treat MS by restoring myelin. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
MS News Today columnist and forums moderator Ed Tobias discusses a survey about MS fatigue.
Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today columnist, Jenn Powell discusses, ‘Act Myself’, a digital tool designed to help meet the emotional needs in those with Multiple Sclerosis. Are you interested in learning more about Multiple Sclerosis? If so, please visit
https://multiplesclerosisnewstoday.com/
MS News Today columnist and forums moderator Ed Tobias takes a look at three new disease-modifying treatments for MS. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today columnist, Jenn Powell discusses the prodrome period preceding diagnosis in those with Multiple Sclerosis. Are you interested in learning more about Multiple Sclerosis? If so, please visit
https://multiplesclerosisnewstoday.com/
MS News Todays columnist and forums moderator Ed Tobias wondered whether he was having a relapse or something less serious called a pseudo-relapse. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today columnist, Jenn Powell discusses the benefits mindfulness has on those with Multiple Sclerosis. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
MS News Todays columnist Ed Tobias says sometimes you just need to give your laptop the weekend off. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today columnist, Jenn Powell discusses the National Multiple Sclerosis Society’s recommendation on exercise. Are you interested in learning more about Multiple Sclerosis? If so, please visit
https://multiplesclerosisnewstoday.com/
MS News Todays columnist Ed Tobias discusses more research connecting MS with the Epstein-Barr virus.
Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today columnist, Jenn Powell discusses the recent breakthrough device designation to the Helius PoNs Device by the FDA Are you interested in learning more about Multiple Sclerosis? If so, please visit
https://multiplesclerosisnewstoday.com/
MS News Todays columnist Ed Tobias discusses the greatest concerns of MS patients and suggests that comprehensive care is one way to approach them. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today columnist, Jenn Powell discusses the commonalities of pain and fatigue in patients with Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis. Are you interested in learning more about Multiple Sclerosis? If so, please visit
https://multiplesclerosisnewstoday.com/
MS News Today columnist Ed Tobias shares some concerns he, and other people with MS, are having about MS treatment and tests in a COVID-19 world. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today columnist, Jenn Powell discusses Telehealth, and the use of technology, to provide access to healthcare for those living with MS . Are you interested in learning more about Multiple Sclerosis? If so, please visit
https://multiplesclerosisnewstoday.com/
MS News Today columnist Ed Tobias shares some experiences with his MS stress-reliever…a Cocker Spaniel named Joey. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today columnist, Jenn Powell discusses accepted applications for shortened infusion time of Ocrevus in both US and Europe. Are you interested in learning more about Multiple Sclerosis? If so, please visit
https://multiplesclerosisnewstoday.com/
MS News Today columnist Ed Tobias shares some early information about COVID-19 and people with MS. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today columnist, Jenn Powell discusses the link between systematic inflammation and fat metabolism, which may increase the potential for cardiovascular disease in those with MS. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
MS News Today columnist Ed Tobias marks the second anniversary of the completion of his Lemtrada treatments. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today columnist, Jenn Powell discusses how Plegridy and Avonex, may be used in women with relapsing multiple sclerosis who are, or are considering becoming, pregnant. Are you interested in learning more about Multiple Sclerosis? If so, please visit
https://multiplesclerosisnewstoday.com/
MS News Today columnist Ed Tobias takes a look at how a pair of neurologists are using telemedicine to examine some of their MS patients. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today columnist, Jenn Powell discusses how using broad and specific language can help those with Multiple Sclerosis talk about their disease. Are you interested in learning more about Multiple Sclerosis? If so, please visit
https://multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today columnist, Jenn Powell discusses the reintroduction of Cortrophin Gel (in the U.S) to treat acute exacerbations in Multiple Sclerosis and other diseases. Are you interested in learning more about Multiple Sclerosis? If so, please visit
https://multiplesclerosisnewstoday.com/
MS News Today columnist and forums moderator Ed Tobias reports on the FDA’s approval of Zeposia as a new disease-modifying therapy. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
MS News Today columnist and forums moderator Ed Tobias discusses the impact of the noval coronavirus on people with MS who are using disease-modifying therapies. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today columnist, Jenn Powell discusses the prevalence of sexual dysfunction in women with Multiple Sclerosis. Are you interested in learning more about Multiple Sclerosis? If so, please visit
https://multiplesclerosisnewstoday.com/
MS News Today’s columnist and forums moderator, Ed Tobias, reports on the cost of MS medications and what might be driving them so high. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today columnist, Jenn Powell discusses the Multiple Sclerosis Association of America’s efforts to mark Multiple Sclerosis Awareness Month through hosting a wealth of wellness activities. Are you interested in learning more about Multiple Sclerosis? If so, please visit
https://multiplesclerosisnewstoday.com/
MS News Today’s columnist and forums moderator, Ed Tobias, reports on how MS isn’t rare… but it is invisible. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today columnist, Jenn Powell, discusses how MS patients with dysphagia, who pace feeding tubes by age 50, may extend their life by more than two years. Are you interested in learning more about Multiple Sclerosis? If so, please visit multiplesclerosisnewstoday.com/
MS News Today’s columnist and forums moderator, Ed Tobias, reports about a new process that may make diagnosing MS faster by scanning for damaged myelin. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today columnist, Jenn Powell talks about aspects of ACTRIMS 2020, recently held in West Palm Beach, Florida. Are you interested in learning more about Multiple Sclerosis? If so, please visit
https://multiplesclerosisnewstoday.com/
MS News Today’s columnist and forums moderator, Ed Tobias, reports on some MS statistics and a possible link between smoking and MS. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today columnist, Jenn Powell discusses how urinary incontinence, associated with poor functioning of the pelvic floor muscles, can negatively impact quality of life in those with Multiple Sclerosis. Are you interested in learning more about Multiple Sclerosis? If so, please visit
https://multiplesclerosisnewstoday.com/
MS News Today’s columnist and forums moderator, Ed Tobias, discusses a recent study of the problems people with MS have with bladder control. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
MS News Today’s columnist and forums moderator, Ed Tobias, reports on a study involving cognitive decline in MS patients. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
MS News Today’s columnist and forums moderator, Ed Tobias, discusses April Hester, a person with MS who is planning a 2,200 mile trail hike. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
MS News Today’s columnist, Jenn Powell, discusses EyeStat’s promise of early detection in the onset of neurodegenerative disorders such as Multiple Sclerosis. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
MS News Today’s columnist and forums moderator, Ed Tobias, discusses a new trial of HSCT for people with MS. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses the new imaging agent Myeliviz, currently in clinical trial for use in MS diagnosis. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
MS News Today’s columnist and forums moderator, Ed Tobias, talks about trouble breathing that almost had him calling the medics. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
MS News Today’s forums moderator, Jenn Powell, discusses a study that suggests how specific changes in a vitamin D receptor proteins are linked to MS risks. Are you interested in learning more about Multiple Sclerosis? If so, please visit
https://multiplesclerosisnewstoday.com/
MS News Today’s columnist and forums moderator, Ed Tobias, discusses how some patients and neurologists weigh the risks versus benefits of Tysabri.
Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
MS News Today’s columnist, Jennifer Powell, discusses the impact of SPMS on fiscal responsibilities. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
MS News Today’s columnist and forums moderator, Ed Tobias, discusses his experience using the Bioness L300 Go, Functional Electronic Stimulator. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
MS News Today’s columnist, Jennifer Powell, discusses New York Stem Cell Institute and Aspen Neuroscience’s endeavor to send 3 dimensional brain cell models of PPMS and Parkinson’s Disease to the International Space Station for long-term study of how these cells behave when exposed to microgravity. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
MS News Today’s columnist and forums moderator, Ed Tobias, discusses his experience being treated with Lemtrada. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
MS News Today’s columnist, Jennifer Powell, discusses TD Bank Group’s $1 Million donation to the Multiple Sclerosis Society of Canada to support research projects aiming to use Artificial Intelligence to create better DMT’s for people living with Multiple Sclerosis. Are you interested in learning more about Multiple Sclerosis? If so, please visit
https://multiplesclerosisnewstoday.com/
MS News Today’s columnist and forums moderator, Ed Tobias, discusses the approval of a generic form of the MS treatment Gilenya in the U.S. Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/